rfhg_2756.1

Basic information about the TSS

---

TSS ID: rfhg_2756.1 Species: human Chr: chr1		Start: 20652884 End: 20652884 Strand: -
Source datasets	PRJDB5282
Protocol	C1CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000475210.1:-200 GeneID: 1650 HGNC/MGI_ID: HGNC:2728 UniProt_ID: Nearer transcript ids and distances:

Gene_name: dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit Gene_symbol: DDOST Gene_synonyms: KIAA0115 OST OST48 WBP1 Gene_source: HGNC:2728

TATA-Box annotation

---

Distance to TSS:	-691
Nearest PromoterID:	NR_046507
Entrez ID:	100861548
Nearest Unigene:	Hs.710259
Nearest Refseq:	NR_046507
Nearest Ensembl:	ENSG00000117242
Gene Name:	dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit
Gene Alias:	NAPINK1|PINK1-AS1|PINK1AS
Gene Type:	ncRNA
CpG%:	0.000000
GC%:	1.000000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@DDOST p2@DDOST p3@DDOST p4@DDOST p5@DDOST
Sample		p1@DDOST	p2@DDOST	p3@DDOST	p4@DDOST	p5@DDOST
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	66.62	4.09	1.56	4.09	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	70.00	6.47	3.03	6.47	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	66.17	7.33	1.16	4.63	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	68.40	7.28	1.87	2.91	0.42
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	61.64	6.52	1.80	4.95	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	56.98	6.78	2.91	4.26	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	87.81	10.46	2.40	5.45	0.44
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	64.67	10.42	2.66	3.39	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	72.02	9.40	2.78	5.77	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	52.17	11.01	2.32	2.90	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	44.47	10.91	5.26	2.83	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	42.28	9.76	3.66	2.85	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	139.59	6.13	4.03	11.12	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	117.57	6.01	2.86	8.72	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	117.46	5.27	5.49	9.22	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	108.14	7.04	3.77	6.54	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	106.15	6.55	4.59	8.30	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	107.56	5.06	5.06	4.64	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	89.04	5.86	4.27	6.93	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	136.00	6.32	4.96	10.98	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	130.85	4.28	3.07	9.89	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	143.62	4.14	3.63	9.84	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	119.05	6.85	4.65	7.50	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	121.33	6.79	4.37	7.52	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	112.23	6.71	4.90	9.55	1.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	98.75	8.23	3.17	12.03	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	98.90	4.95	3.30	10.44	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	139.09	7.78	4.01	11.32	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	126.47	5.17	2.58	10.66	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	131.92	8.69	4.89	9.77	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	115.56	4.19	3.35	8.79	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	113.71	6.06	4.49	6.25	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	109.74	4.64	4.01	6.75	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	117.11	7.26	2.80	8.58	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	129.96	4.30	4.30	9.91	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	123.02	7.86	3.83	11.31	0.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	125.29	7.15	4.70	10.01	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	120.29	5.04	5.24	9.47	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	126.68	7.56	3.78	7.56	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	118.35	9.36	4.56	9.12	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	127.04	7.29	4.23	11.29	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	106.14	6.44	3.66	7.76	0.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	124.01	5.91	5.06	6.33	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	120.63	6.47	5.07	10.84	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	127.69	5.62	4.22	13.25	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	116.56	8.61	7.21	9.77	1.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	107.96	7.44	5.76	10.08	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	115.94	7.75	5.07	10.43	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	119.69	9.81	4.07	10.29	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	112.22	7.28	5.86	8.49	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	121.74	8.61	5.94	11.89	1.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	125.20	10.90	8.01	12.45	1.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	69.96	13.99	0.00	27.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	127.39	9.94	6.39	14.19	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	130.57	8.28	4.97	14.91	1.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	73.83	10.91	3.36	11.75	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	90.93	11.94	3.21	9.18	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	154.28	14.91	10.37	17.18	1.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	146.77	14.45	10.60	14.77	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	99.33	11.00	7.54	13.52	1.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	124.09	11.28	9.17	15.51	2.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	125.06	7.85	6.17	10.09	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	67.67	12.74	5.57	11.94	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	83.58	12.23	5.44	10.53	1.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	136.47	18.85	9.42	10.40	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	124.60	15.97	7.10	13.13	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	32.33	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	47.38	7.90	0.00	15.79	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	109.69	16.09	7.31	13.65	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	109.09	14.88	5.95	13.88	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	104.61	22.52	10.32	17.36	1.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	90.75	24.84	11.59	15.57	3.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	135.49	26.29	13.92	14.23	4.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	137.59	21.40	11.92	23.54	2.45
Adipocyte - breast, donor1	11376-118A8	70.01	17.11	12.04	12.20	0.79
Adipocyte - breast, donor2	11327-117E4	59.84	11.55	8.82	8.50	1.93
Adipocyte - omental, donor1	11473-119C6	69.47	17.56	11.07	9.29	0.89
Adipocyte - omental, donor2	11474-119C7	81.48	23.17	9.72	18.69	3.74
Adipocyte - omental, donor3	11475-119C8	95.45	14.40	7.70	11.05	0.00
Adipocyte - perirenal, donor1	11476-119C9	142.91	21.69	12.12	18.50	1.91
Adipocyte - subcutaneous, donor1	11259-116F8	31.89	13.19	8.80	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	60.52	22.58	7.68	10.39	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	75.59	13.90	11.12	8.34	1.56
Adipocyte differentiation, day04, donor1	13019-139D4	113.82	12.32	9.39	15.06	2.54
Adipocyte differentiation, day04, donor2	13022-139D7	71.29	14.16	5.66	9.52	0.77
Adipocyte differentiation, day04, donor3	13025-139E1	79.45	17.56	8.64	7.25	1.39
Adipocyte differentiation, day04, donor4	13028-139E4	62.90	15.28	12.34	12.34	1.76
Adipocyte differentiation, day08, donor1	13020-139D5	59.76	8.28	4.67	8.69	0.80
Adipocyte differentiation, day08, donor2	13023-139D8	53.90	14.20	6.13	12.59	1.61
Adipocyte differentiation, day08, donor3	13026-139E2	39.99	11.20	2.67	8.00	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	61.76	8.90	7.79	7.23	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	63.22	7.90	7.07	11.64	2.50
Adipocyte differentiation, day12, donor2	13024-139D9	44.46	15.07	7.79	7.28	1.00
Adipocyte differentiation, day12, donor3	13027-139E3	48.11	7.85	5.56	8.84	0.98
Adipocyte differentiation, day12, donor4	13030-139E6	28.92	6.39	4.57	6.70	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	93.48	12.38	6.19	8.40	0.88
Alveolar Epithelial Cells, donor2	11590-120G6	112.59	12.19	7.17	7.17	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	147.36	17.97	17.97	10.78	3.59
Amniotic Epithelial Cells, donor1	11533-120A3	103.63	13.85	15.11	11.51	2.16
Amniotic Epithelial Cells, donor2	11613-122A2	140.57	18.41	18.41	16.73	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	133.13	12.94	12.74	9.66	2.26
Anulus Pulposus Cell, donor1	11248-116E6	103.10	12.36	15.10	12.70	2.75
Anulus Pulposus Cell, donor2	11463-119B5	120.74	13.47	15.92	14.69	1.96
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	75.48	24.26	14.83	14.83	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	69.46	19.54	9.99	8.68	1.74
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	89.89	34.24	10.70	17.12	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	66.96	21.22	8.07	13.45	2.09
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	59.44	22.76	12.65	16.44	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	62.05	20.46	13.86	15.18	2.64
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	65.95	18.84	8.12	8.12	0.65
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	72.33	16.99	6.80	14.56	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	80.77	21.38	13.07	10.69	1.19
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	83.24	19.21	9.42	13.18	1.13
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	72.57	21.77	9.43	11.61	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	63.94	13.79	8.78	12.54	2.51
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	72.15	17.79	10.54	8.73	1.32
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	62.78	20.47	5.46	9.55	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	83.09	20.21	11.31	15.38	1.66
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	65.37	17.15	9.11	12.86	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	90.31	19.27	10.39	13.41	0.76
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	72.97	19.78	14.17	9.62	2.14
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	66.33	20.48	11.71	6.83	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	92.22	18.41	9.95	12.61	0.50
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	63.64	18.01	16.81	8.41	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	70.80	28.32	3.54	7.08	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	87.65	14.58	8.58	14.24	1.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	62.92	16.78	16.78	16.78	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	68.93	17.48	5.83	10.19	1.46
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	98.28	19.73	6.45	14.42	3.04
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	76.32	21.80	19.38	7.27	4.85
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	68.40	22.80	15.39	13.11	1.14
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	91.28	17.74	11.54	13.25	1.71
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	76.39	16.26	12.39	11.87	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	69.44	23.46	9.85	13.61	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	82.32	17.36	6.75	10.93	1.93
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	74.91	23.54	14.27	12.13	2.85
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	54.99	14.62	6.43	9.94	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	80.69	13.25	8.73	12.34	1.20
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	77.22	13.07	14.26	26.14	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	79.84	15.77	11.70	13.22	1.53
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	92.45	16.81	7.90	10.95	1.27
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	73.07	19.06	9.53	15.88	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	81.56	23.73	10.79	12.95	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	83.62	15.45	7.62	12.07	1.48
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	70.76	18.85	10.44	12.47	2.61
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	72.74	24.56	7.56	5.67	1.89
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	80.52	16.44	6.61	12.71	1.19
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	62.54	32.43	13.90	6.95	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	65.49	31.69	10.56	6.34	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	93.48	18.01	10.72	12.65	1.07
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	64.98	21.06	12.63	10.23	1.80
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	60.51	24.79	10.21	10.21	2.19
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	90.57	16.32	9.20	11.03	1.61
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	61.21	30.60	7.65	12.75	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	77.29	21.36	15.00	9.92	1.53
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	99.71	17.96	9.08	13.42	1.45
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	75.89	20.20	12.85	12.85	1.53
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	81.26	21.99	7.65	12.91	1.91
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	101.56	18.40	10.42	12.42	0.89
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	64.08	18.31	10.68	12.21	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	70.34	21.05	9.97	10.52	1.66
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	95.86	18.27	9.80	12.18	1.32
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	77.41	20.72	11.63	10.18	2.18
Astrocyte - cerebellum, donor1	11500-119F6	91.62	15.84	11.30	10.32	1.97
Astrocyte - cerebellum, donor2	11580-120F5	131.62	16.60	15.40	16.60	2.40
Astrocyte - cerebellum, donor3	11661-122F5	135.92	8.60	7.97	11.96	2.31
Astrocyte - cerebral cortex, donor1	11235-116D2	73.90	9.06	3.49	7.32	1.05
Astrocyte - cerebral cortex, donor2	11316-117D2	96.90	7.60	5.99	8.57	0.81
Astrocyte - cerebral cortex, donor3	11392-118C6	103.52	11.04	8.05	11.49	1.19
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	96.34	9.29	6.31	8.49	1.95
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	95.59	6.77	6.01	9.77	1.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	86.03	6.60	6.26	6.15	1.14
Basophils, donor1	12241-129G9	46.29	22.23	11.51	6.54	2.35
Basophils, donor2	12242-129H1	68.91	19.48	14.07	6.49	3.97
Basophils, donor3	12243-129H2	55.86	20.43	14.55	5.88	2.50
Bronchial Epithelial Cell, donor1	11511-119G8	71.80	8.62	8.41	7.11	0.43
Bronchial Epithelial Cell, donor2	11591-120G7	108.35	13.26	10.52	8.23	1.83
Bronchial Epithelial Cell, donor3	11672-122G7	107.60	7.17	7.17	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	57.74	5.65	4.39	4.39	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	83.39	10.61	5.61	5.20	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	95.11	9.44	8.29	6.68	0.69
Bronchial Epithelial Cell, donor7	11769-123I5	86.73	7.38	7.92	9.18	0.90
Burkitt's lymphoma cell line:DAUDI	10422-106C8	81.93	7.42	3.71	4.12	0.82
Burkitt's lymphoma cell line:RAJI	10476-106I8	145.10	12.58	5.59	11.41	1.40
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	144.54	29.74	30.38	12.47	7.35
CD133+ stem cells - cord blood derived, pool1	12223-129E9	186.15	31.03	31.03	10.34	10.34
CD14+ Monocytes, donor1	11224-116B9	39.45	21.98	16.34	4.51	3.38
CD14+ Monocytes, donor2	11305-117B9	35.64	23.20	14.29	3.34	2.60
CD14+ Monocytes, donor3	11381-118B4	46.32	20.86	19.32	3.73	1.54
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	59.72	53.21	31.70	11.60	6.23
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	73.54	56.48	38.29	8.72	7.58
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	64.10	42.08	38.46	9.86	5.59
CD14+ monocytes - mock treated, donor1	11863-125A9	44.09	17.63	7.95	4.48	1.59
CD14+ monocytes - mock treated, donor2	11873-125C1	29.57	17.80	6.64	4.53	0.91
CD14+ monocytes - mock treated, donor3	11883-125D2	31.03	16.35	6.40	3.55	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	31.14	15.23	5.36	4.35	1.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	22.08	13.80	4.14	2.21	0.55
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	22.31	10.17	5.21	2.23	1.24
CD14+ monocytes - treated with BCG, donor1	11860-125A6	32.11	13.71	6.46	5.68	1.57
CD14+ monocytes - treated with BCG, donor2	11870-125B7	29.38	13.89	8.37	3.03	0.71
CD14+ monocytes - treated with BCG, donor3	11880-125C8	26.12	16.32	7.62	3.70	2.18
CD14+ monocytes - treated with Candida, donor1	11868-125B5	32.54	12.41	6.79	3.98	1.17
CD14+ monocytes - treated with Candida, donor2	11878-125C6	31.15	14.78	6.34	2.64	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	15.53	13.31	7.77	2.22	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	37.34	16.36	8.33	2.97	0.89
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	25.94	11.57	5.79	2.79	0.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	22.07	12.49	5.00	1.87	0.62
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	36.38	14.41	7.32	3.89	2.06
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	22.85	12.44	9.05	2.04	1.13
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	17.46	13.09	4.80	1.75	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	37.39	20.44	9.95	4.57	1.34
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	35.07	21.11	8.20	4.88	1.40
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	32.82	14.73	8.42	1.68	0.84
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	26.82	12.86	6.80	4.23	1.47
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	25.72	12.33	7.05	3.17	0.70
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	14.48	7.46	2.63	2.19	0.88
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	28.25	12.73	7.32	3.84	0.70
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	25.65	11.89	7.81	5.20	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	24.57	14.23	9.48	2.59	2.37
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	36.44	18.84	7.78	2.05	1.23
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	16.69	11.82	6.03	2.55	1.16
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	16.47	11.14	5.80	0.46	1.86
CD14+CD16+ Monocytes, donor1	11789-124B7	37.49	23.10	12.64	4.36	2.18
CD14+CD16+ Monocytes, donor2	11801-124D1	33.96	22.87	12.24	6.24	1.39
CD14+CD16+ Monocytes, donor3	11912-125G4	36.17	20.80	12.35	6.07	2.38
CD14+CD16- Monocytes, donor1	11788-124B6	49.83	37.22	21.49	8.10	2.96
CD14+CD16- Monocytes, donor2	11799-124C8	37.02	30.74	15.19	6.81	2.97
CD14+CD16- Monocytes, donor3	11910-125G2	39.91	30.32	16.95	7.80	2.68
CD14-CD16+ Monocytes, donor1	11790-124B8	39.55	17.10	10.46	5.61	2.04
CD14-CD16+ Monocytes, donor2	11800-124C9	33.81	21.52	8.12	6.15	1.10
CD14-CD16+ Monocytes, donor3	11911-125G3	39.79	22.11	10.74	5.90	1.26
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	73.16	6.10	14.23	6.10	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	78.65	9.49	8.81	6.78	2.71
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	93.20	13.46	10.36	4.14	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	89.55	11.19	10.13	10.13	1.60
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	79.87	5.90	10.19	5.36	4.82
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	91.95	10.53	6.32	5.62	1.40
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	91.77	10.98	11.77	9.41	2.35
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	75.14	9.23	10.55	5.27	2.64
CD19+ B Cells, donor1	11544-120B5	57.53	6.58	7.40	3.29	0.82
CD19+ B Cells, donor2	11624-122B4	55.86	5.08	8.71	3.63	2.90
CD19+ B Cells, donor3	11705-123B4	56.54	4.54	9.09	2.52	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	35.56	36.77	10.10	6.06	0.81
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	29.16	30.76	12.38	3.99	1.60
CD34+ Progenitors, donor1	11545-120B6	65.26	8.03	9.04	2.01	1.00
CD34+ Progenitors, donor2	11625-122B5	55.06	13.48	12.36	2.25	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	140.16	27.81	20.67	13.90	2.25
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	135.52	37.43	22.32	11.73	3.83
CD4+ T Cells, donor1	11225-116C1	61.77	6.07	7.86	1.43	1.43
CD4+ T Cells, donor2	11306-117C1	63.69	10.41	10.41	3.06	3.06
CD4+ T Cells, donor3	11382-118B5	66.49	3.66	8.54	4.88	3.66
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	56.92	7.91	4.08	5.62	1.02
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	72.10	7.19	7.64	6.51	1.57
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	61.80	8.05	8.05	6.90	1.72
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	65.42	5.69	11.85	2.84	3.32
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	80.06	3.51	9.13	4.92	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	62.63	9.89	13.18	3.30	6.59
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	70.38	16.04	14.74	7.23	3.76
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	91.00	14.40	12.88	8.64	3.90
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	79.80	14.67	11.28	8.06	1.93
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	50.66	8.97	13.90	2.69	2.69
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	53.81	8.04	13.28	5.24	3.49
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	48.84	7.04	7.48	0.88	0.88
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	42.16	13.49	12.23	5.48	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	97.03	22.23	15.37	9.56	4.78
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	93.89	19.05	18.71	7.02	3.68
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	61.73	5.98	12.24	0.82	3.81
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	61.10	8.04	12.33	5.36	2.14
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	46.62	10.76	12.55	3.59	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	69.35	21.14	14.83	7.05	2.23
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	69.97	17.98	14.30	6.93	3.90
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	75.02	21.02	20.38	5.67	3.36
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	63.71	9.61	18.20	1.52	4.55
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	70.19	6.93	9.96	6.07	2.60
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	49.68	8.72	6.97	3.49	2.18
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	112.34	10.39	16.83	4.95	5.94
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	108.94	23.08	12.00	3.69	2.77
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	83.75	16.75	16.75	9.77	8.37
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	80.03	14.40	15.23	5.82	1.66
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	86.13	13.74	13.25	7.12	5.40
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	78.54	18.48	23.10	12.32	6.16
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	99.91	16.47	16.83	6.80	5.73
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	92.79	11.08	24.93	11.08	2.77
CD8+ T Cells, donor1	11226-116C2	72.03	12.11	12.77	2.95	2.62
CD8+ T Cells, donor2	11307-117C2	66.08	6.01	18.02	3.75	2.25
CD8+ T Cells, donor3	11383-118B6	92.16	9.59	11.11	4.80	1.77
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	70.42	13.53	2.98	10.32	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	66.38	8.87	2.16	9.35	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	69.22	7.93	3.28	6.84	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	77.75	6.30	2.70	9.61	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	60.24	6.24	1.68	8.16	0.72
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	63.44	8.41	2.50	6.37	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	76.92	9.13	2.39	10.21	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	71.07	14.48	2.37	8.69	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	74.58	9.62	2.81	10.32	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	92.98	10.87	3.02	10.26	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	85.70	12.20	2.61	10.46	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	89.52	11.72	4.26	12.52	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	39.84	3.50	0.44	4.38	0.88
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	48.28	4.10	2.73	5.01	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	45.50	4.48	1.49	8.20	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	61.95	7.92	3.24	9.36	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	68.77	4.89	2.30	8.63	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	48.79	6.60	1.65	7.54	0.94
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	74.79	12.36	1.58	11.41	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	78.12	10.76	4.92	10.46	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	66.68	9.30	3.21	9.30	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	76.49	12.62	1.15	11.47	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	70.54	12.61	2.76	7.49	0.79
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	62.78	10.59	3.78	3.78	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	48.98	5.62	0.80	8.03	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	55.25	11.19	3.50	6.29	1.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	37.06	14.02	2.00	8.01	0.00
Cardiac Myocyte, donor1	11525-119I4	85.90	7.31	1.83	10.97	0.00
Cardiac Myocyte, donor2	11605-120I3	134.39	27.17	15.81	18.78	2.47
Cardiac Myocyte, donor3	11686-122I3	104.60	13.68	9.58	13.15	1.16
Chondrocyte - de diff, donor1	11261-116G1	103.65	35.36	20.45	19.76	1.39
Chondrocyte - de diff, donor2	11338-117F6	63.26	16.35	7.82	9.60	1.07
Chondrocyte - de diff, donor3	11410-118E6	100.47	16.73	10.92	15.47	1.37
Chondrocyte - re diff, donor2	11339-117F7	52.82	24.17	25.07	12.53	6.27
Chondrocyte - re diff, donor3	11411-118E7	113.64	17.79	50.15	12.13	13.35
Ciliary Epithelial Cells, donor1	11242-116D9	87.45	6.89	8.61	7.69	2.18
Ciliary Epithelial Cells, donor2	11323-117D9	109.66	8.98	7.91	8.76	0.64
Ciliary Epithelial Cells, donor3	11399-118D4	126.55	7.61	7.43	8.41	1.50
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	67.77	8.53	8.25	9.81	2.02
Corneal Epithelial Cells, donor1	11526-119I5	91.78	11.42	11.86	9.44	0.66
Corneal Epithelial Cells, donor2	11606-120I4	79.63	10.24	6.83	3.41	1.14
Corneal Epithelial Cells, donor3	11687-122I4	98.42	12.53	11.76	10.23	2.05
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	71.82	34.34	19.98	9.74	1.49
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	72.86	33.43	18.29	8.52	2.21
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	65.56	34.51	6.90	10.35	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	79.48	33.15	17.06	12.42	1.94
Dendritic Cells - plasmacytoid, donor1	11228-116C4	107.96	22.89	19.82	9.91	1.37
Dendritic Cells - plasmacytoid, donor2	11309-117C4	109.68	18.93	31.99	8.49	3.92
Dendritic Cells - plasmacytoid, donor3	11385-118B8	108.89	21.29	28.55	6.78	3.39
Endothelial Cells - Aortic, donor0	11207-116A1	53.20	23.68	16.18	11.34	1.33
Endothelial Cells - Aortic, donor1	11263-116G3	78.04	19.36	12.91	15.26	1.76
Endothelial Cells - Aortic, donor2	11340-117F8	82.86	35.92	21.21	16.12	2.26
Endothelial Cells - Aortic, donor3	11412-118E8	102.23	29.10	16.91	13.37	2.75
Endothelial Cells - Artery, donor1	11264-116G4	90.75	34.03	16.58	13.67	1.45
Endothelial Cells - Artery, donor2	11341-117F9	79.99	19.53	10.82	10.59	1.41
Endothelial Cells - Artery, donor3	11413-118E9	76.26	22.44	13.67	10.69	1.23
Endothelial Cells - Lymphatic, donor1	11236-116D3	69.82	21.28	15.74	10.20	1.55
Endothelial Cells - Lymphatic, donor2	11317-117D3	70.89	20.08	9.13	13.69	1.52
Endothelial Cells - Lymphatic, donor3	11393-118C7	66.25	12.40	11.84	8.46	0.56
Endothelial Cells - Microvascular, donor1	11265-116G5	69.83	19.31	13.67	8.02	1.78
Endothelial Cells - Microvascular, donor2	11342-117G1	66.12	26.55	13.54	7.81	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	69.33	10.07	9.50	4.82	0.99
Endothelial Cells - Thoracic, donor1	11266-116G6	68.02	26.01	14.40	14.00	1.60
Endothelial Cells - Thoracic, donor2	11343-117G2	98.54	31.97	17.30	18.34	1.57
Endothelial Cells - Umbilical vein, donor1	11243-116E1	92.81	26.84	23.73	13.67	3.73
Endothelial Cells - Umbilical vein, donor2	11324-117E1	86.47	29.76	21.73	10.65	3.48
Endothelial Cells - Umbilical vein, donor3	11400-118D5	79.75	25.52	21.37	13.56	2.44
Endothelial Cells - Vein, donor1	11267-116G7	75.08	25.03	13.65	14.79	2.28
Endothelial Cells - Vein, donor2	11344-117G3	59.37	29.34	18.86	9.78	0.70
Endothelial Cells - Vein, donor3	11416-118F3	110.53	24.18	18.68	16.33	1.26
Eosinophils, donor1	12244-129H3	30.49	30.49	15.25	15.25	0.00
Eosinophils, donor2	12245-129H4	8.25	4.95	18.15	1.65	1.65
Eosinophils, donor3	12246-129H5	3.57	7.13	7.13	3.57	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	77.94	8.06	7.09	8.55	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	58.24	10.40	8.32	6.24	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	146.42	0.00	16.27	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	97.29	16.42	11.49	15.19	1.23
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	93.39	30.11	13.58	19.27	1.20
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	54.17	1.63	1.19	2.28	0.22
Fibroblast - Aortic Adventitial, donor1	11245-116E3	101.27	16.01	11.76	15.40	2.06
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	97.71	24.43	13.10	17.60	1.50
Fibroblast - Aortic Adventitial, donor2	11326-117E3	121.61	25.73	12.13	16.98	1.05
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	1005.48	55.33	21.08	61.39	1.58
Fibroblast - Aortic Adventitial, donor3	11401-118D6	227.89	12.29	6.98	21.26	1.33
Fibroblast - Cardiac, donor1	11268-116G8	101.16	15.88	11.34	13.61	1.36
Fibroblast - Cardiac, donor2	11345-117G4	64.43	21.22	17.43	10.61	2.27
Fibroblast - Cardiac, donor3	11417-118F4	131.22	18.45	11.99	16.09	1.73
Fibroblast - Cardiac, donor4	11452-119A3	80.63	14.85	6.97	13.64	0.30
Fibroblast - Cardiac, donor5	11456-119A7	97.72	18.91	13.32	15.99	2.28
Fibroblast - Cardiac, donor6	11460-119B2	90.50	20.31	11.82	12.73	1.82
Fibroblast - Choroid Plexus, donor1	11492-119E7	95.00	19.56	11.52	10.85	1.47
Fibroblast - Choroid Plexus, donor2	11572-120E6	101.82	7.33	12.51	8.63	1.73
Fibroblast - Choroid Plexus, donor3	11653-122E6	130.37	19.04	16.11	17.58	4.39
Fibroblast - Conjunctival, donor1	11531-120A1	105.63	22.14	20.53	11.07	1.38
Fibroblast - Conjunctival, donor3	11692-122I9	92.77	9.16	7.63	9.84	2.04
Fibroblast - Dermal, donor1	11269-116G9	62.69	16.43	14.09	8.22	1.64
Fibroblast - Dermal, donor2	11346-117G5	43.87	11.79	13.68	9.43	1.42
Fibroblast - Dermal, donor3	11418-118F5	73.14	20.55	16.80	11.36	1.69
Fibroblast - Dermal, donor4	11450-119A1	69.98	16.50	13.79	10.17	1.36
Fibroblast - Dermal, donor5	11454-119A5	62.11	19.54	17.45	11.86	2.27
Fibroblast - Dermal, donor6	11458-119A9	70.98	22.58	16.73	12.67	3.57
Fibroblast - Gingival, donor1	11237-116D4	59.97	19.57	15.41	14.58	2.29
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	88.03	19.13	13.62	12.58	2.62
Fibroblast - Gingival, donor2	11318-117D4	68.40	14.36	10.81	10.02	2.64
Fibroblast - Gingival, donor3	11394-118C8	73.19	15.57	15.57	13.05	2.03
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	96.62	17.66	9.35	24.93	2.08
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	80.88	12.16	10.57	8.81	1.23
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	82.63	18.08	21.51	14.97	2.49
Fibroblast - Gingival, donor6 (control)	11922-125H5	67.07	19.07	13.66	12.04	2.03
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	56.81	10.94	11.29	8.47	2.82
Fibroblast - Gingival, donor7 (control)	11924-125H7	87.45	23.11	15.06	11.70	2.19
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	67.90	16.64	13.09	10.77	1.91
Fibroblast - Gingival, donor8 (control)	11926-125H9	75.36	21.94	13.05	14.15	2.52
Fibroblast - Gingival, donor9 (control)	11927-125I1	96.99	21.13	16.43	19.37	3.08
Fibroblast - Lung, donor1	11270-116H1	69.33	16.31	2.72	6.80	2.72
Fibroblast - Lung, donor2	11347-117G6	40.29	10.45	5.97	4.48	0.00
Fibroblast - Lung, donor3	11419-118F6	97.71	15.19	15.41	14.14	2.32
Fibroblast - Lymphatic, donor1	11506-119G3	98.30	39.15	16.66	13.33	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	54.55	18.18	15.38	11.19	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	69.97	21.55	12.59	10.08	1.68
Fibroblast - Mammary, donor1	11540-120B1	84.85	34.51	18.67	19.89	2.03
Fibroblast - Mammary, donor2	11620-122A9	79.88	15.98	19.97	19.97	0.00
Fibroblast - Mammary, donor3	11701-123A9	41.69	23.83	0.00	17.87	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	71.19	16.49	14.55	14.74	2.72
Fibroblast - Periodontal Ligament, donor2	11319-117D5	66.74	14.11	17.90	9.56	1.82
Fibroblast - Periodontal Ligament, donor3	11395-118C9	50.79	16.22	10.71	9.18	1.84
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	76.32	18.70	16.03	14.88	1.14
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	108.81	25.11	17.01	14.85	1.62
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	106.23	16.24	12.41	15.31	2.09
Fibroblast - Pulmonary Artery, donor1	11250-116E8	86.44	19.12	11.83	13.15	1.44
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	73.35	28.85	15.44	12.39	1.63
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	90.21	21.38	23.39	23.39	3.34
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	105.96	14.23	15.81	16.61	2.77
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	132.76	35.72	21.04	17.07	2.78
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	96.62	26.82	15.99	18.83	2.31
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	70.75	19.12	12.61	10.84	2.17
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	210.60	80.63	31.59	41.52	6.02
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	78.37	26.66	11.55	16.73	1.84
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	103.25	26.57	11.64	16.20	1.01
Fibroblast - skin normal, donor1	11553-120C5	100.42	25.60	18.05	15.26	1.97
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	168.23	41.50	24.06	26.87	4.81
Fibroblast - skin normal, donor2	11561-120D4	83.68	21.70	11.85	12.16	1.31
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	106.99	28.71	16.32	14.21	1.81
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	77.79	14.50	11.76	12.18	1.82
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	77.44	9.23	5.47	10.94	1.03
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	211.84	53.21	29.89	33.50	4.27
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	88.09	20.98	10.87	11.72	2.45
Fibroblast - skin walker warburg, donor1	11554-120C6	80.97	20.58	14.00	11.47	1.69
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	82.17	19.92	12.86	16.62	3.76
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	37.48	6.97	6.10	4.36	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	58.59	11.09	7.63	5.20	0.69
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	88.22	9.37	8.07	6.51	1.04
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	75.89	6.39	4.09	5.88	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	127.08	10.72	7.66	4.59	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	111.02	6.38	8.29	5.10	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	207.10	7.42	6.28	7.13	0.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	154.98	3.31	0.83	4.69	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	103.43	4.57	1.14	4.79	0.91
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	181.69	5.75	3.37	7.73	0.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	145.65	2.11	2.11	6.61	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	106.65	3.59	1.96	7.18	0.65
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	195.02	6.63	3.98	7.96	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	128.60	3.67	2.83	3.25	0.42
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	105.53	5.17	3.57	3.94	0.37
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	122.22	3.22	2.95	2.15	1.07
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	92.42	5.82	3.35	4.46	0.87
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	104.93	5.68	2.63	3.05	0.69
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	101.24	4.68	2.03	3.25	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	104.05	5.02	4.11	5.02	0.68
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	95.17	5.36	4.48	4.11	0.62
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	117.38	5.68	5.25	5.03	1.31
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	114.94	5.61	6.50	5.32	1.18
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	98.40	8.42	4.29	5.72	1.43
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	119.98	6.48	6.03	5.36	1.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	93.15	8.07	4.23	4.44	0.81
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	92.79	7.12	6.79	5.43	0.85
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	93.90	7.09	7.54	7.27	1.51
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	70.97	6.45	6.76	4.68	1.04
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	61.48	5.98	5.12	4.27	1.02
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	94.39	7.19	3.87	4.09	1.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	89.02	8.82	6.41	6.91	1.25
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	90.25	9.60	3.27	4.29	1.02
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	110.99	6.19	7.22	5.98	1.24
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	99.15	6.69	4.96	5.07	1.50
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	102.89	9.01	6.00	7.17	2.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	90.60	4.85	6.39	4.63	1.10
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	95.81	8.24	4.06	5.78	1.60
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	97.42	6.65	5.02	6.48	0.65
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	93.65	8.34	8.98	4.81	1.60
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	89.54	8.24	5.69	5.69	0.66
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	80.83	10.44	8.70	6.80	0.79
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	84.84	9.73	7.91	6.08	1.22
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	89.07	9.51	5.75	5.96	1.67
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	85.63	11.20	6.81	5.93	0.66
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	86.97	7.57	5.33	3.09	1.40
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	86.48	10.74	5.09	6.85	0.93
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	89.58	9.89	8.29	5.62	0.80
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	77.73	10.56	7.96	8.42	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	78.37	12.82	6.48	6.48	0.91
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	121.17	12.47	8.13	11.11	0.81
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	108.58	11.25	10.14	9.40	1.84
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	103.52	9.21	8.77	7.46	1.10
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	79.34	7.93	8.93	5.95	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	99.07	9.76	11.34	8.18	1.85
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	106.93	13.72	11.70	12.51	1.01
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	55.15	6.10	7.12	5.08	2.80
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	117.64	3.38	1.59	3.38	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	111.24	3.08	1.69	2.93	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	146.07	4.09	1.43	5.32	0.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	122.04	3.44	0.94	4.07	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	106.24	5.37	2.26	5.37	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	130.06	3.23	2.77	3.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	121.27	2.47	0.00	7.42	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	117.20	3.09	2.71	4.25	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	112.31	11.23	3.21	8.02	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	140.85	6.96	1.74	3.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	113.92	6.51	3.58	3.91	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	123.54	4.53	1.24	6.59	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	129.96	3.33	0.00	6.66	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	116.89	3.08	1.96	6.71	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	109.17	4.25	2.94	3.60	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	123.31	4.19	0.84	5.87	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	120.55	4.45	3.50	3.82	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	116.50	3.40	1.70	5.43	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	156.61	0.00	0.00	6.26	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	129.43	6.30	2.29	4.01	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	107.74	3.55	3.55	3.55	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	118.59	1.69	0.00	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	118.88	5.38	2.07	5.38	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	102.18	4.14	2.76	5.75	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	121.18	0.00	0.00	5.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	114.17	6.54	3.84	4.61	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	107.90	3.91	2.61	2.93	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	116.38	3.34	1.34	5.35	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	116.74	4.24	1.93	4.62	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	117.76	5.48	0.68	2.40	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	94.42	2.48	4.97	7.45	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	116.08	2.83	3.77	4.72	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	95.96	3.02	2.41	4.22	2.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	121.06	2.54	1.02	2.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	112.47	2.39	2.79	4.79	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	103.60	2.96	2.47	1.48	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	125.13	2.36	1.18	2.36	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	126.02	3.50	2.92	2.92	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	107.96	2.19	4.83	4.39	2.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	116.13	0.00	1.70	4.24	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	108.64	1.79	3.58	1.19	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	103.36	3.40	0.97	4.85	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	63.91	18.26	18.26	7.99	2.28
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	99.80	19.54	16.63	11.64	3.33
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	60.72	12.37	12.37	6.75	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	52.97	13.32	11.42	5.39	1.27
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	71.85	16.71	15.87	11.70	3.34
Hep-2 cells mock treated, biol_rep1	11898-125E8	56.16	5.69	3.48	5.57	0.35
Hep-2 cells mock treated, biol_rep2	11899-125E9	48.61	5.91	2.53	5.40	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	45.27	4.10	2.05	3.41	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	60.34	4.26	3.83	4.37	0.44
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	51.15	8.38	2.15	3.87	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	53.82	5.81	2.37	3.44	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	57.91	5.60	1.37	5.11	0.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	45.29	5.66	2.92	4.80	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	54.78	7.05	2.24	3.52	0.96
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	101.85	34.70	24.06	16.23	1.68
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	89.16	22.07	20.77	19.04	3.46
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	89.89	26.44	18.51	10.58	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	148.50	23.63	12.70	15.52	1.41
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	142.40	25.43	18.89	19.62	2.18
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	113.30	18.88	13.29	17.66	1.40
Hepatocyte, donor1	11523-119I2	101.69	13.32	4.84	13.32	1.21
Hepatocyte, donor2	11603-120I1	121.74	4.31	3.23	5.39	0.00
Hepatocyte, donor3	11684-122I1	121.48	20.25	4.29	20.86	1.84
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	73.10	15.01	8.48	3.92	3.92
Intestinal epithelial cells (polarized), donor1	11246-116E4	111.69	15.38	10.31	8.56	1.57
Iris Pigment Epithelial Cells, donor1	11530-119I9	89.73	10.84	6.72	11.25	1.37
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	79.60	22.29	9.55	9.55	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	113.48	26.70	26.70	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	81.25	27.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	69.22	20.77	19.38	8.31	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	75.08	20.02	17.52	10.01	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	201.76	71.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	46.13	30.75	12.81	10.25	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	54.85	32.00	18.28	9.14	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	87.71	22.74	11.37	9.75	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	58.36	23.34	11.67	3.33	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	36.31	25.41	10.89	14.52	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	75.44	25.15	5.29	10.59	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	68.74	22.17	12.20	6.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	89.05	31.43	41.91	5.24	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	54.80	23.93	6.30	5.04	1.89
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	81.97	17.01	10.83	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	175.62	43.90	29.27	14.63	14.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	80.11	24.55	7.11	7.11	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	72.45	9.66	16.10	4.83	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	95.59	35.84	71.69	35.84	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	66.82	25.26	10.59	7.33	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	57.51	23.09	17.21	8.82	0.84
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	28.74	0.00	14.37	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	70.72	24.91	9.64	8.84	1.61
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	74.79	24.93	13.85	5.54	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	120.65	60.32	15.08	15.08	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	72.22	18.88	11.33	8.50	2.36
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	65.30	19.05	15.42	3.63	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	103.20	58.97	14.74	44.23	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	76.40	35.51	10.76	6.46	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	91.47	45.74	8.89	7.62	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	131.44	16.43	16.43	32.86	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	69.51	25.51	7.65	5.74	1.28
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	80.20	27.34	5.47	9.11	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	142.24	15.80	47.41	15.80	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	60.70	22.14	8.57	9.28	1.43
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	46.46	16.59	6.64	3.32	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	125.09	62.55	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	72.23	24.69	8.64	8.64	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	82.53	22.83	12.29	19.32	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	62.86	40.86	15.72	3.14	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	72.32	29.21	6.26	5.56	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	88.52	22.13	24.34	19.92	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	81.05	22.69	9.73	6.48	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	80.22	28.77	7.85	9.59	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	83.24	29.25	4.50	9.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	62.72	13.94	10.45	3.48	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	75.74	30.94	9.60	5.33	2.13
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	65.12	20.78	9.70	5.54	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	54.14	22.80	11.40	2.85	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	69.03	23.01	8.28	7.36	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	121.01	27.23	9.08	6.05	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	49.67	37.25	18.63	6.21	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	80.36	24.32	11.63	6.34	0.00
Keratinocyte - epidermal, donor1	11272-116H3	38.19	4.24	4.41	3.10	0.24
Keratinocyte - epidermal, donor2	11349-117G8	45.68	8.78	5.27	4.10	0.59
Keratinocyte - epidermal, donor3	11421-118F8	91.53	7.48	5.21	5.68	1.04
Keratinocyte - oral, donor1	11251-116E9	115.11	11.01	11.47	9.99	1.36
Keratocytes, donor1	11527-119I6	147.16	28.54	16.50	22.69	3.09
Keratocytes, donor2	11607-120I5	79.68	24.61	24.61	14.06	2.34
Keratocytes, donor3	11688-122I5	99.98	23.51	16.40	14.23	1.38
Krukenberg tumor cell line:HSKTC	10687-109F3	87.92	13.19	2.20	13.19	0.00
Lens Epithelial Cells, donor1	11529-119I8	73.35	15.10	9.71	11.87	2.16
Lens Epithelial Cells, donor2	11609-120I7	93.30	4.15	8.07	9.80	2.19
Lens Epithelial Cells, donor3	11690-122I7	131.08	16.15	10.19	17.56	1.11
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	78.02	19.68	15.18	11.15	2.02
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	65.02	22.05	15.91	8.93	1.67
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	92.72	21.88	13.69	10.86	1.42
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	56.46	23.12	13.98	7.53	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	71.86	18.59	15.13	6.30	2.21
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	77.95	15.53	13.05	9.60	1.19
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	55.40	17.65	16.83	13.13	1.64
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	74.33	20.23	17.44	9.10	2.53
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	75.86	18.58	11.96	8.30	1.27
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	45.49	15.43	13.45	8.31	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	70.19	15.90	12.41	12.99	2.13
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	78.50	18.51	12.96	10.37	1.11
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	64.46	13.59	16.03	12.19	0.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	65.36	21.47	15.03	8.83	2.39
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	84.61	19.23	15.11	10.85	1.24
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	54.51	14.17	12.93	4.93	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	66.09	16.21	13.40	9.98	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	83.44	17.20	15.37	9.70	1.10
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	59.57	16.78	9.87	8.23	1.97
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	70.00	21.38	12.59	8.49	2.05
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	81.40	18.67	16.43	9.46	2.24
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	57.71	16.49	13.09	7.27	2.42
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	74.06	15.89	15.62	6.73	1.89
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	77.35	19.07	13.32	10.60	1.51
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	57.54	13.48	12.96	8.81	3.11
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	68.26	21.78	17.17	7.75	1.88
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	85.41	20.75	11.13	10.98	1.20
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	51.59	20.64	13.76	9.63	2.06
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	73.75	18.06	15.62	6.96	1.13
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	75.71	16.43	11.66	8.69	1.59
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	56.21	18.41	13.08	5.33	2.42
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	67.15	15.55	17.20	6.28	1.98
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	83.38	15.98	12.02	10.16	0.62
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	66.64	13.70	8.51	10.74	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	71.90	17.79	14.08	8.15	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	81.12	17.46	13.75	9.76	1.37
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	56.93	13.83	15.44	10.94	1.29
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	76.39	16.74	14.91	6.70	1.83
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	77.82	17.92	11.62	10.36	1.40
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	58.31	13.16	12.44	9.24	3.91
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	60.60	22.30	16.48	9.70	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	86.98	15.56	10.89	11.83	2.18
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	60.88	16.47	10.74	12.89	2.15
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	75.46	18.29	15.35	7.84	2.94
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	86.17	16.01	13.65	10.59	0.71
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	73.76	15.96	13.86	8.54	1.86
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	67.11	16.65	14.86	7.94	2.05
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	74.59	17.30	10.44	7.46	1.19
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	70.25	6.80	22.66	9.06	4.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	103.56	12.27	4.60	5.37	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	61.60	8.16	7.42	6.68	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	66.01	7.62	5.08	2.96	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	87.92	5.63	4.92	9.85	2.11
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	79.39	7.47	2.80	10.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	45.86	10.82	4.12	2.58	1.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	59.47	5.95	5.95	4.76	2.38
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	68.99	9.05	4.98	5.20	1.13
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	70.67	12.80	6.98	6.98	1.74
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	77.43	7.65	4.95	6.75	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	65.85	10.03	5.96	6.50	1.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	63.16	10.27	6.68	4.11	1.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	79.75	11.29	5.29	5.29	1.76
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	77.29	7.33	6.66	8.66	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	62.15	4.58	4.58	8.66	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	94.18	9.07	3.74	7.74	1.87
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	95.61	9.64	5.67	8.88	0.94
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	61.36	9.20	1.84	4.29	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	80.73	6.52	3.26	6.52	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	97.87	8.33	3.75	6.25	1.67
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	67.26	11.77	6.45	7.29	1.96
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	92.73	7.21	6.18	2.06	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	92.61	6.97	5.23	6.68	1.74
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	75.93	8.97	8.07	5.98	0.90
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	103.46	7.19	4.43	4.43	2.21
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	73.17	6.72	4.24	6.36	2.47
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	70.44	10.33	5.90	6.64	1.11
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	70.23	6.91	5.76	10.36	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	91.72	8.83	6.91	6.91	1.54
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	60.01	4.53	1.70	7.36	2.26
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	73.02	10.67	4.10	9.85	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	81.34	7.23	6.78	6.33	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	85.46	7.90	6.46	8.62	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	68.72	8.96	2.24	5.23	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	82.49	8.92	7.43	5.20	1.11
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	80.12	11.20	3.88	5.17	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	82.20	6.85	4.28	5.14	1.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	90.62	11.66	3.66	4.33	1.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	85.07	13.27	5.43	4.83	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	90.30	6.40	3.55	7.82	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	76.65	8.25	6.87	4.12	1.37
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	65.48	5.90	4.29	3.76	1.61
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	88.88	6.06	4.04	4.71	2.02
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	75.19	7.04	7.04	7.41	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	60.47	5.81	8.14	4.65	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	81.45	13.75	9.52	4.23	2.12
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	85.23	8.80	6.40	6.40	1.20
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	59.60	10.18	3.63	8.00	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	103.48	9.96	2.30	3.07	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	80.90	8.88	4.93	3.95	0.99
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	47.99	9.41	1.88	6.59	1.88
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	91.51	8.05	5.03	6.54	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	83.82	8.11	4.51	7.21	0.90
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	55.08	13.77	5.16	6.88	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	82.83	9.35	5.34	5.34	2.23
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	75.47	9.38	3.13	5.08	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	63.33	13.19	3.30	3.96	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	106.38	11.94	6.75	5.71	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	71.32	7.88	5.25	7.88	1.31
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	69.89	8.95	5.59	7.27	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	83.47	11.48	5.30	7.51	2.21
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	75.60	10.41	5.01	5.01	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	60.76	6.58	4.05	5.57	2.53
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	88.91	8.17	7.69	7.69	0.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	71.96	9.14	4.77	6.36	1.19
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	50.43	8.51	9.11	4.86	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	50.49	10.38	4.84	3.46	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	90.44	6.46	4.18	6.84	1.90
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	72.30	5.68	4.13	5.68	1.03
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	53.81	6.05	5.44	3.02	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	78.91	7.92	4.12	3.17	1.58
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	64.50	8.53	5.86	4.80	3.73
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	43.67	13.22	4.60	5.17	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	78.16	6.69	4.63	5.14	1.54
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	74.27	5.66	4.24	7.78	1.41
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	56.75	15.32	7.38	2.27	2.84
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	81.54	9.15	6.24	6.66	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	58.73	10.18	3.92	5.48	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	65.55	8.77	5.01	5.01	0.84
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	88.75	9.76	7.43	4.65	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	60.21	4.68	5.35	8.03	2.68
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	64.16	3.74	5.35	4.28	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	72.74	9.29	6.87	8.49	1.21
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	68.83	8.26	8.26	6.42	1.84
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	57.79	8.00	4.45	3.56	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	92.32	7.98	4.56	3.42	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	57.52	3.83	5.37	4.60	1.53
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	62.93	5.47	7.66	4.38	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	76.62	6.24	4.45	4.45	0.89
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	69.41	9.36	4.94	6.50	1.30
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	65.65	14.59	4.64	3.98	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	93.54	2.08	10.39	4.16	0.00
Macrophage - monocyte derived, donor1	11232-116C8	48.55	34.87	26.44	11.85	4.33
Macrophage - monocyte derived, donor2	11313-117C8	62.94	36.70	27.89	12.11	2.94
Macrophage - monocyte derived, donor3	11389-118C3	81.14	38.93	27.26	15.07	3.80
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	70.63	11.68	5.31	9.56	0.53
Mallassez-derived cells, donor2	11929-125I3	86.99	9.67	5.07	7.61	0.16
Mallassez-derived cells, donor3	11930-125I4	64.21	10.84	5.14	6.25	0.83
Mammary Epithelial Cell, donor1	11273-116H4	82.11	13.25	5.58	9.47	0.90
Mammary Epithelial Cell, donor2	11350-117G9	68.91	6.66	5.50	5.79	0.87
Mammary Epithelial Cell, donor3	11422-118F9	89.54	8.98	5.24	4.49	0.25
Mast cell - stimulated, donor1	11487-119E2	44.74	14.91	10.17	3.39	0.68
Mast cell, donor1	11563-120D6	62.61	30.50	15.03	9.62	2.16
Mast cell, donor2	11565-120D8	44.58	45.76	41.60	10.10	5.05
Mast cell, donor3	11566-120D9	49.53	49.53	42.55	10.81	5.63
Mast cell, donor4	11567-120E1	43.61	48.40	33.15	7.98	4.43
Mast cell, expanded and stimulated, donor5	11940-126A5	71.97	38.04	18.08	15.08	2.99
Mast cell, expanded and stimulated, donor8	11942-126A7	53.12	36.77	15.18	6.42	1.75
Mast cell, expanded, donor5	11939-126A4	49.90	46.46	24.78	8.95	2.87
Mast cell, expanded, donor8	11941-126A6	55.40	43.35	18.91	12.55	1.51
Melanocyte - dark, donor1	11502-119F8	91.74	14.73	10.85	10.45	0.80
Melanocyte - dark, donor2	11582-120F7	124.94	23.88	17.30	15.57	1.38
Melanocyte - dark, donor3	11663-122F7	62.88	15.21	7.03	10.14	1.09
Melanocyte - light, donor1	11274-116H5	54.77	9.64	5.17	4.47	1.18
Melanocyte - light, donor2	11351-117H1	63.47	9.55	4.09	8.19	0.00
Melanocyte - light, donor3	11423-118G1	71.11	8.67	3.47	6.94	2.60
Melanocyte, donor1 (MC+1)	12641-134G4	68.51	16.14	6.04	7.39	1.25
Melanocyte, donor2 (MC+2)	12739-135I3	90.36	22.05	6.45	11.30	1.08
Melanocyte, donor3 (MC+3)	12837-137B2	50.89	4.02	3.75	4.02	0.00
Meningeal Cells, donor1	11493-119E8	71.58	19.85	13.65	7.94	1.98
Meningeal Cells, donor2	11573-120E7	114.88	26.85	7.92	12.76	0.88
Meningeal Cells, donor3	11654-122E7	50.21	16.87	17.85	7.42	3.26
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	100.37	16.54	13.40	15.68	1.43
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	110.59	18.62	11.27	13.18	1.01
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	59.14	15.77	18.40	9.20	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	75.87	27.47	24.86	15.70	6.54
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	96.88	22.96	21.53	15.79	2.87
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	72.85	12.07	5.29	12.49	1.06
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	74.89	12.57	9.55	11.06	1.51
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	78.23	20.88	19.34	12.09	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	82.56	20.46	19.00	13.15	2.19
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	74.88	25.58	15.14	14.73	3.48
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	90.31	19.95	16.48	13.44	2.35
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	104.45	15.61	7.81	14.87	1.49
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	96.44	12.24	11.71	12.63	1.58
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	122.55	20.77	11.87	16.02	1.19
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	137.80	14.01	18.68	14.01	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	142.17	27.54	21.77	19.85	1.28
Mesenchymal stem cells - adipose, donor0	11217-116B2	81.17	25.87	18.08	15.24	3.54
Mesenchymal stem cells - hepatic, donor0	11218-116B3	101.32	14.39	10.01	17.51	1.56
Mesenchymal stem cells - umbilical, donor0	11214-116A8	132.08	32.66	18.87	18.87	0.00
Mesothelial Cells, donor1	11247-116E5	111.64	12.46	9.02	16.44	1.06
Mesothelial Cells, donor2	12156-128G5	103.60	9.51	8.01	13.01	2.50
Mesothelial Cells, donor3	11402-118D7	83.18	6.72	3.90	9.39	0.65
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	39.16	22.96	32.41	8.10	4.05
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	62.31	37.43	23.15	9.11	2.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	53.89	30.03	23.26	10.89	2.06
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	48.40	24.20	27.66	6.91	10.37
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	48.35	22.63	20.46	6.82	2.48
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	50.61	26.97	19.50	7.05	1.45
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	13.90	13.90	16.21	4.63	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	64.82	35.54	22.52	7.26	3.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	42.36	36.77	29.79	10.24	3.72
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	77.86	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	44.50	26.01	15.85	5.89	1.83
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	53.85	39.20	17.82	12.27	3.96
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	34.21	25.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	23.89	23.89	13.27	8.85	1.77
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	58.13	27.74	22.80	12.92	3.04
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	19.74	26.32	17.11	3.95	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	41.60	25.68	18.25	8.49	1.49
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	23.94	18.42	21.18	6.45	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	37.85	24.14	18.18	7.75	1.19
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	31.86	18.44	15.09	1.68	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	41.65	28.85	24.34	5.77	3.26
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	36.84	22.10	17.59	6.42	1.19
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	24.33	19.35	16.03	6.08	3.87
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	38.91	30.62	17.50	7.60	2.07
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	48.80	25.45	18.30	7.15	1.26
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	37.30	23.64	18.14	4.69	1.63
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	36.90	26.82	18.88	5.36	4.29
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	37.34	20.45	14.89	6.22	2.45
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	41.27	10.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	32.20	22.56	20.37	5.48	1.97
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	19.26	17.24	13.18	6.08	2.03
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	29.83	31.48	16.57	4.97	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	28.54	22.56	18.21	7.61	1.36
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	38.52	26.76	20.00	6.47	2.35
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	29.44	22.90	8.72	8.72	1.09
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	34.60	28.83	15.86	6.73	0.96
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	45.63	20.81	16.01	9.61	2.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	34.28	23.31	10.97	8.23	1.37
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	34.04	24.53	22.53	5.51	1.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	53.89	107.79	26.95	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	18.35	10.19	8.15	4.08	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	36.79	28.90	19.27	10.95	2.63
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	20.97	12.14	20.97	3.31	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	25.62	16.65	14.09	5.76	1.28
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	32.73	28.76	21.07	5.70	2.23
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	30.62	22.96	18.09	6.26	3.48
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	22.10	28.73	6.63	4.42	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	48.20	23.25	16.41	4.79	1.37
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	35.01	16.19	12.25	10.07	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	19.89	14.56	10.30	3.20	1.42
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	40.12	14.87	15.43	5.89	1.68
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	43.64	26.18	9.14	9.98	1.66
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	27.97	15.15	13.99	4.08	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	31.98	15.38	13.57	6.94	2.11
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	48.42	21.70	8.77	6.68	2.50
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	43.31	7.22	14.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	35.10	18.47	9.24	6.46	1.85
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	51.22	19.92	14.80	7.40	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	35.93	17.55	7.60	3.87	0.83
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	42.76	15.81	12.44	6.22	1.55
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	43.76	24.45	16.30	8.15	0.86
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	38.11	12.07	6.99	5.72	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	34.16	13.08	10.14	4.00	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	59.87	27.24	13.77	9.28	1.50
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	33.34	10.88	6.07	6.64	0.85
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	42.68	15.61	11.47	5.73	1.59
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	65.01	24.10	18.35	7.74	1.77
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	35.27	17.82	11.76	7.58	1.90
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	40.63	14.77	15.34	6.53	1.14
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	66.37	24.58	18.19	12.29	1.72
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	43.01	11.08	7.82	6.52	1.30
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	51.45	16.47	13.53	5.59	1.18
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	79.87	24.80	12.11	12.11	3.17
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	49.05	18.96	9.48	5.77	1.65
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	45.56	12.80	10.12	6.25	1.19
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	33.90	41.44	18.83	7.53	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	51.69	32.08	40.99	7.13	3.56
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	64.40	38.44	22.67	6.90	0.99
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	52.60	30.51	27.35	12.62	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	49.22	52.19	52.19	9.29	7.71
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	44.70	36.32	40.05	12.11	4.66
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	49.57	48.82	39.43	10.51	5.63
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	48.74	38.62	32.49	10.12	5.59
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	40.60	28.50	21.49	8.03	2.94
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	47.15	44.20	30.21	7.37	3.68
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	62.29	39.57	28.58	9.16	3.30
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	49.78	26.45	31.11	7.78	3.11
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	37.41	20.31	12.29	2.14	1.07
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	42.50	15.46	46.37	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	62.62	46.46	28.28	7.07	2.02
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	35.84	24.03	18.13	7.17	2.95
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	17.71	5.45	2.72	2.72	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	7.63	8.90	5.72	1.27	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	14.58	7.29	4.05	4.86	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	10.57	9.06	6.04	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	11.42	0.00	5.71	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	29.36	13.05	16.31	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	28.51	28.51	9.50	14.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	12.55	50.20	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	69.59	11.85	7.11	7.54	0.86
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	60.62	13.59	10.45	9.41	1.05
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	100.79	23.36	9.34	16.69	1.33
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	94.74	32.55	12.10	19.20	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	73.97	22.06	11.98	14.26	2.85
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	110.11	15.96	25.53	25.53	3.19
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	93.15	21.76	14.28	23.12	2.72
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	31.24	11.03	3.68	14.70	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	117.19	29.72	18.42	22.60	2.51
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	115.06	39.05	17.20	20.92	2.56
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	91.88	20.27	18.11	19.19	2.16
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	97.13	15.56	13.03	14.93	2.10
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	66.81	0.00	11.13	33.40	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	104.73	22.34	11.91	18.86	1.49
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	93.92	18.68	12.99	17.32	3.25
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	111.98	24.94	12.69	19.27	2.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	110.07	19.92	11.59	15.84	1.14
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	88.94	14.76	11.48	12.58	1.28
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	126.24	23.34	20.16	16.97	2.65
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	106.85	18.61	10.21	18.01	2.40
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	71.87	8.86	6.89	10.83	1.97
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	120.18	20.49	14.31	17.89	1.95
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	80.61	12.88	8.47	10.94	1.41
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	111.11	21.10	11.95	11.95	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	131.02	27.12	18.85	21.15	3.22
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	144.28	20.57	11.25	21.21	1.29
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	72.08	14.49	3.45	14.14	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	68.27	20.23	0.00	17.70	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	72.18	10.92	10.03	7.80	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	112.62	19.90	13.97	16.09	0.85
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	67.17	21.36	13.29	13.77	2.37
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	157.53	21.89	16.31	26.61	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	81.25	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	107.63	13.33	7.00	17.99	1.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	78.90	13.53	5.86	7.66	1.80
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	73.01	19.84	11.11	12.70	1.98
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	105.87	15.79	10.22	19.50	3.71
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	113.89	22.32	11.35	17.03	1.89
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	105.59	24.44	11.41	16.95	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	88.03	13.95	7.41	10.02	1.31
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	68.30	11.31	3.62	9.05	3.17
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	68.79	16.76	7.06	13.23	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	93.74	21.94	9.31	13.96	3.32
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	126.49	11.41	7.94	11.41	1.98
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	92.26	15.31	11.48	17.99	2.30
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	187.21	27.22	13.31	35.08	4.23
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	54.81	11.27	10.39	9.28	1.33
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	79.29	23.04	4.74	18.30	2.03
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	35.77	10.22	5.11	15.33	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	150.59	19.51	10.36	14.63	1.83
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	87.81	21.09	7.87	15.11	0.63
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	110.47	15.74	12.11	14.22	3.63
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	73.58	10.28	11.87	11.08	3.16
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	43.08	7.94	5.67	6.80	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	30.35	20.23	5.06	20.23	0.00
Myoblast, donor1	11241-116D8	82.86	25.22	17.02	13.04	2.11
Myoblast, donor2	11322-117D8	110.28	21.29	17.26	16.69	2.49
Myoblast, donor3	11398-118D3	89.29	20.68	15.13	14.46	2.86
NK T cell leukemia cell line:KHYG-1	10777-110G3	71.80	12.99	7.30	7.59	2.19
Natural Killer Cells, donor1	11230-116C6	59.66	14.45	26.14	2.46	4.31
Natural Killer Cells, donor2	11311-117C6	69.66	9.95	16.59	3.02	3.32
Natural Killer Cells, donor3	11387-118C1	77.85	13.80	14.17	5.15	2.94
Neural stem cells, donor1	11275-116H6	53.35	7.62	7.26	6.53	0.00
Neural stem cells, donor2	11352-117H2	36.59	3.85	1.93	3.85	0.00
Neurons, donor1	11494-119E9	86.48	1.14	5.69	2.28	1.14
Neurons, donor2	11574-120E8	60.54	3.74	3.74	5.06	0.88
Neurons, donor3	11655-122E8	85.51	7.40	5.76	5.76	0.82
Neutrophils, donor1	11233-116C9	6.50	6.50	15.78	0.00	0.00
Neutrophils, donor2	11314-117C9	8.70	14.49	2.90	0.00	2.90
Neutrophils, donor3	11390-118C4	6.72	4.89	5.50	1.22	2.44
Nucleus Pulposus Cell, donor1	11252-116F1	91.66	8.31	8.31	8.91	1.07
Nucleus Pulposus Cell, donor2	11409-118E5	139.68	9.77	14.00	12.37	4.23
Nucleus Pulposus Cell, donor3	11462-119B4	105.69	10.03	7.42	10.63	1.40
Olfactory epithelial cells, donor1	11933-125I7	70.06	4.68	3.17	7.02	1.10
Olfactory epithelial cells, donor2	11934-125I8	91.62	8.83	6.80	9.41	1.16
Olfactory epithelial cells, donor3	11935-125I9	68.90	8.51	4.65	9.99	0.34
Olfactory epithelial cells, donor4	11936-126A1	67.98	6.14	4.97	7.99	0.58
Oligodendrocyte - precursors, donor1	11496-119F2	92.08	7.82	7.22	6.62	0.60
Osteoblast - differentiated, donor1	11276-116H7	54.88	15.74	12.55	10.42	2.77
Osteoblast - differentiated, donor2	11353-117H3	105.17	10.29	17.15	13.72	2.29
Osteoblast - differentiated, donor3	11425-118G3	154.56	12.41	7.45	6.83	0.00
Osteoblast, donor1	11277-116H8	196.81	14.85	9.97	14.46	1.56
Osteoblast, donor2	11354-117H4	75.85	16.15	11.94	14.75	2.11
Osteoblast, donor3	11426-118G4	126.37	13.69	12.26	12.97	2.31
Pancreatic stromal cells, donor1	11249-116E7	85.67	19.96	13.90	15.67	3.62
Pericytes, donor1	11491-119E6	109.71	13.24	12.80	16.13	1.78
Pericytes, donor2	11571-120E5	114.31	18.11	14.49	16.75	2.04
Pericytes, donor3	11652-122E5	125.53	30.52	20.75	24.01	3.05
Perineurial Cells, donor1	11499-119F5	85.44	14.92	14.81	13.34	2.60
Perineurial Cells, donor2	11579-120F4	128.17	20.43	13.34	16.56	1.66
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	45.26	16.26	11.47	3.51	0.96
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	46.52	16.65	11.75	5.14	3.18
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	56.68	14.24	12.29	4.92	2.07
Placental Epithelial Cells, donor1	11278-116H9	71.27	14.11	8.61	5.50	2.87
Placental Epithelial Cells, donor2	11355-117H5	96.47	8.87	5.54	6.65	0.00
Placental Epithelial Cells, donor3	11427-118G5	121.92	8.25	6.68	6.48	2.16
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	70.25	13.29	12.03	12.34	0.95
Preadipocyte - breast, donor1	11467-119B9	61.72	12.57	8.25	7.13	1.31
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	59.39	11.09	7.31	9.66	0.65
Preadipocyte - breast, donor2	11328-117E5	93.66	15.08	10.13	12.61	1.13
Preadipocyte - omental, donor1	11468-119C1	73.95	13.43	8.42	9.16	1.70
Preadipocyte - omental, donor2	11329-117E6	75.51	17.90	12.22	8.29	1.75
Preadipocyte - omental, donor3	11403-118D8	115.46	19.05	9.88	14.04	1.00
Preadipocyte - perirenal, donor1	11469-119C2	138.78	22.64	5.91	13.78	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	50.06	11.06	6.76	7.99	0.92
Preadipocyte - subcutaneous, donor2	11356-117H6	99.52	24.79	16.65	14.87	2.48
Preadipocyte - subcutaneous, donor3	11428-118G6	167.05	28.61	18.73	22.48	3.07
Preadipocyte - visceral, donor1	11280-116I2	87.65	20.86	16.11	14.53	2.42
Preadipocyte - visceral, donor2	11357-117H7	99.40	30.83	12.89	15.65	2.76
Preadipocyte - visceral, donor3	11429-118G7	96.76	20.58	13.27	12.64	2.51
Prostate Epithelial Cells (polarized), donor1	11253-116F2	147.99	20.67	8.15	8.00	1.66
Prostate Epithelial Cells, donor2	11331-117E8	77.19	10.16	9.21	9.61	1.35
Prostate Epithelial Cells, donor3	11404-118D9	60.44	18.37	14.27	7.72	1.84
Prostate Stromal Cells, donor1	11254-116F3	102.62	23.35	13.55	19.48	1.94
Prostate Stromal Cells, donor2	11332-117E9	102.92	19.01	14.16	13.27	2.33
Prostate Stromal Cells, donor3	11405-118E1	122.32	22.94	13.45	18.04	2.09
Renal Cortical Epithelial Cells, donor1	11516-119H4	104.75	9.12	8.03	8.39	1.09
Renal Cortical Epithelial Cells, donor2	11596-120H3	67.93	6.86	7.35	5.68	0.62
Renal Epithelial Cells, donor1	11517-119H5	89.78	8.62	5.58	8.12	2.03
Renal Epithelial Cells, donor2	11597-120H4	129.46	11.38	12.09	11.38	0.71
Renal Epithelial Cells, donor3	11678-122H4	82.26	6.88	8.15	7.30	1.91
Renal Glomerular Endothelial Cells, donor1	11514-119H2	96.68	53.79	25.19	13.62	2.72
Renal Glomerular Endothelial Cells, donor2	11594-120H1	93.66	38.81	21.83	16.58	1.35
Renal Glomerular Endothelial Cells, donor3	11675-122H1	98.79	24.20	13.54	16.43	2.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	74.53	21.96	9.98	11.31	1.33
Renal Mesangial Cells, donor1	11518-119H6	128.09	15.63	11.22	12.77	1.54
Renal Mesangial Cells, donor2	11598-120H5	137.94	10.66	15.05	9.40	1.88
Renal Mesangial Cells, donor3	11679-122H5	149.80	8.60	8.60	12.21	1.11
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	104.15	10.47	9.13	9.66	0.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	102.05	8.01	6.75	6.75	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	148.88	10.41	8.10	8.10	1.16
Retinal Pigment Epithelial Cells, donor0	11215-116A9	100.60	9.59	7.00	8.04	2.59
Retinal Pigment Epithelial Cells, donor1	11528-119I7	105.74	4.55	6.25	8.53	1.14
Retinal Pigment Epithelial Cells, donor2	11608-120I6	108.06	18.52	8.23	9.26	3.09
Retinal Pigment Epithelial Cells, donor3	11689-122I6	64.23	4.27	2.26	5.52	0.50
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	68.96	15.77	12.16	8.82	2.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	99.17	23.23	25.02	8.04	8.04
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	56.69	19.26	12.66	4.40	1.65
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	49.30	13.34	12.76	5.80	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	95.05	25.88	13.78	13.78	2.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	116.98	23.73	17.08	13.90	3.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	130.50	29.00	19.97	15.95	3.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	134.34	20.22	11.04	11.66	3.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	128.55	26.34	18.06	17.25	3.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	138.68	29.58	18.95	16.87	3.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	109.80	25.33	13.42	14.38	1.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	116.93	22.54	15.58	14.67	4.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	146.94	28.67	18.99	16.49	5.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	134.28	24.53	14.20	13.34	1.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	121.91	24.47	15.24	15.02	3.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	156.88	33.63	21.02	18.59	4.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	100.18	25.62	11.47	10.90	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	113.47	24.78	16.68	13.97	3.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	108.80	26.31	22.74	12.03	4.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	110.81	24.55	13.40	13.14	2.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	106.59	20.54	15.28	12.95	3.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	140.16	28.26	22.53	14.13	5.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	111.60	24.24	15.49	10.79	2.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	104.27	24.39	18.50	14.86	3.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	122.19	27.86	22.73	14.70	3.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	123.98	27.90	14.04	12.58	3.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	114.05	21.09	17.90	13.73	2.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	139.56	28.07	20.01	18.00	4.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	116.76	26.89	16.04	10.14	2.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	123.41	24.60	13.29	13.29	2.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	145.45	29.00	24.09	16.37	5.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	139.55	30.27	15.55	13.06	2.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	111.27	30.08	21.46	9.29	5.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	124.49	24.65	15.25	15.25	2.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	133.64	27.32	14.27	14.54	2.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	114.95	22.48	17.71	14.30	3.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	130.71	24.48	15.04	14.27	4.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	126.89	30.26	17.37	12.21	3.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	124.69	25.38	18.79	16.46	4.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	125.92	27.25	19.04	16.25	3.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	113.85	28.12	14.49	13.29	3.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	138.04	24.71	18.94	14.20	3.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	125.28	21.59	12.53	14.93	1.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	125.68	20.88	12.17	11.75	2.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	159.29	21.43	20.24	17.14	2.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	142.89	25.80	16.32	14.91	3.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	146.91	22.70	13.09	12.43	2.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	160.36	24.46	16.07	18.52	5.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	129.65	25.69	18.44	13.60	2.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	165.34	26.93	11.99	12.61	3.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	156.91	28.09	20.09	15.87	3.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	241.55	26.16	23.73	21.90	5.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	162.76	31.95	16.58	11.75	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	255.82	41.39	26.46	21.71	3.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	171.94	37.44	25.16	19.77	6.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	179.00	34.83	19.25	20.54	3.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	243.11	38.21	24.12	23.91	5.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	206.74	36.06	22.24	12.02	5.41
Schwann Cells, donor1	11498-119F4	148.95	28.40	21.44	22.19	4.51
Schwann Cells, donor2	11578-120F3	85.06	13.61	23.82	10.21	0.00
Schwann Cells, donor3	11659-122F3	108.01	13.58	17.96	11.17	1.10
Sebocyte, donor1	11220-116B5	64.09	7.67	3.83	3.29	1.10
Sebocyte, donor2	11301-117B5	57.90	4.14	4.60	3.68	0.92
Sebocyte, donor3	11378-118B1	73.38	7.83	5.77	5.57	0.41
Sertoli Cells, donor1	11255-116F4	154.06	49.70	4.97	24.85	3.31
Sertoli Cells, donor2	11333-117F1	183.58	14.12	8.47	16.95	0.00
Skeletal Muscle Cells, donor1	11281-116I3	84.02	9.77	9.24	9.77	1.41
Skeletal Muscle Cells, donor2	11358-117H8	106.26	11.57	5.78	12.29	0.72
Skeletal Muscle Cells, donor3	11430-118G8	80.26	10.03	7.52	16.72	0.84
Skeletal Muscle Cells, donor4	11451-119A2	93.63	14.92	12.10	12.57	1.10
Skeletal Muscle Cells, donor5	11455-119A6	97.96	14.57	13.08	9.51	1.34
Skeletal Muscle Cells, donor6	11459-119B1	94.50	19.39	15.70	12.16	0.77
Skeletal Muscle Satellite Cells, donor1	11240-116D7	109.25	15.50	17.89	11.59	2.65
Skeletal Muscle Satellite Cells, donor2	11321-117D7	100.60	16.12	20.26	11.42	2.71
Skeletal Muscle Satellite Cells, donor3	11397-118D2	94.75	14.78	12.70	11.11	2.88
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	74.06	12.89	8.59	10.28	1.35
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	99.16	13.75	5.07	10.86	2.90
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	122.05	13.21	11.28	12.52	1.93
Skin - palm, donor1	10286-104F7	32.23	10.74	10.74	2.69	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	55.93	16.29	10.09	7.06	0.86
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	18.81	9.00	6.54	7.36	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	44.92	14.54	7.40	7.40	0.78
Small Airway Epithelial Cells, donor1	11256-116F5	72.15	14.04	10.70	10.29	0.83
Small Airway Epithelial Cells, donor2	11334-117F2	70.89	9.56	3.80	5.91	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	94.73	11.63	8.67	12.69	0.63
Small Airway Epithelial Cells, donor3	11406-118E2	79.60	19.79	10.27	9.59	1.20
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	28.39	7.71	3.09	2.47	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	262.13	91.38	42.02	53.80	2.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	73.48	18.81	10.58	7.64	1.18
Smooth Muscle Cells - Aortic, donor1	11283-116I5	71.82	24.53	10.17	13.04	1.33
Smooth Muscle Cells - Aortic, donor2	11360-117I1	88.21	23.63	14.57	17.33	0.79
Smooth Muscle Cells - Aortic, donor3	11432-118H1	97.34	27.04	13.91	13.91	3.09
Smooth Muscle Cells - Bladder, donor1	11519-119H7	116.09	10.01	7.01	8.01	3.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	91.42	19.56	12.38	16.24	1.33
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	137.65	30.81	18.18	25.27	1.33
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	99.10	23.30	10.24	14.98	1.02
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	76.19	11.40	11.72	14.33	0.98
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	92.44	12.11	8.27	10.93	1.18
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	99.51	12.67	8.97	11.67	1.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	79.22	12.69	11.22	10.90	1.79
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	53.88	9.74	7.31	10.96	0.91
Smooth Muscle Cells - Carotid, donor1	11285-116I7	84.86	21.22	13.89	14.65	1.26
Smooth Muscle Cells - Carotid, donor2	11362-117I3	24.48	12.24	12.24	6.12	6.12
Smooth Muscle Cells - Carotid, donor3	11434-118H3	76.77	14.78	8.11	8.58	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	79.64	14.45	9.88	11.21	1.62
Smooth Muscle Cells - Colonic, donor2	11320-117D6	90.83	13.13	7.53	8.18	1.08
Smooth Muscle Cells - Colonic, donor3	11396-118D1	116.50	15.32	8.71	12.59	2.10
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	78.89	22.58	12.53	16.24	1.86
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	88.39	21.56	10.78	9.70	2.16
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	137.77	24.81	6.87	15.84	1.20
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	86.37	17.07	13.66	14.68	2.73
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	86.85	12.17	10.52	11.62	1.65
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	80.92	27.27	20.23	14.29	2.31
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	185.23	33.22	16.84	24.58	3.19
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	96.61	32.61	13.28	14.49	3.62
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	94.84	15.37	10.86	10.86	1.59
Smooth Muscle Cells - Prostate, donor1	11257-116F6	85.49	31.16	14.11	16.38	1.46
Smooth Muscle Cells - Prostate, donor2	11335-117F3	146.13	34.56	25.17	23.17	2.88
Smooth Muscle Cells - Prostate, donor3	11465-119B7	87.26	18.26	11.67	12.43	5.33
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	96.80	22.31	11.01	14.47	2.26
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	131.28	27.76	17.25	21.00	1.50
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	62.03	31.01	5.17	9.05	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	74.88	14.42	12.56	13.02	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	127.23	31.30	14.14	17.67	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	92.76	24.76	13.48	15.04	1.25
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	58.11	12.68	10.62	7.67	1.47
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	62.23	14.75	12.75	10.33	1.92
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	90.63	12.15	9.81	10.74	1.87
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	71.96	20.15	9.35	11.95	1.01
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	86.43	13.26	7.65	11.22	1.27
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	122.22	20.50	9.97	12.97	1.50
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	96.84	16.35	10.20	12.58	0.84
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	128.70	17.09	12.15	18.18	1.76
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	64.28	14.76	14.29	12.38	0.95
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	78.29	16.88	6.61	11.25	0.73
Smooth Muscle Cells - Uterine, donor1	11258-116F7	119.31	36.01	13.26	22.98	1.33
Smooth Muscle Cells - Uterine, donor3	11466-119B8	64.95	17.85	12.00	11.12	1.46
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	52.87	13.22	8.75	9.13	1.17
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	44.43	14.28	9.52	8.73	0.79
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	44.63	10.04	6.70	11.53	2.23
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	62.88	17.25	10.06	12.94	0.72
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	51.67	18.45	10.79	13.91	1.14
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	45.29	13.79	11.03	11.03	1.18
Smooth muscle cells - airway, control, donor1	11966-126D4	66.28	14.98	7.87	9.65	1.27
Smooth muscle cells - airway, control, donor2	11967-126D5	63.89	15.57	10.78	11.18	1.60
Smooth muscle cells - airway, control, donor3	11968-126D6	76.49	12.12	6.27	9.61	1.25
Smooth muscle cells - airway, control, donor4	11969-126D7	78.84	16.50	10.08	18.33	0.92
Synoviocyte, donor1	11291-117A4	56.89	11.61	7.41	8.92	1.51
Synoviocyte, donor2	11368-117I9	128.23	19.28	11.90	24.64	2.01
Synoviocyte, donor3	11440-118H9	93.39	18.32	10.72	16.98	2.23
Trabecular Meshwork Cells, donor1	11532-120A2	180.45	15.37	13.58	15.01	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	89.19	25.77	15.86	19.82	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	114.38	13.89	14.36	14.82	1.62
Tracheal Epithelial Cells, donor1	11292-117A5	79.07	9.18	10.90	7.46	1.08
Tracheal Epithelial Cells, donor2	11369-118A1	67.65	5.80	5.03	5.80	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	69.29	8.02	4.58	4.58	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	69.63	11.56	10.83	8.12	2.21
Urethra, donor2	10319-105A4	55.75	8.99	3.60	1.80	0.00
Urothelial Cells, donor1	11520-119H8	74.39	9.03	8.50	5.31	1.33
Urothelial Cells, donor2	11600-120H7	78.51	10.01	8.01	9.21	2.00
Urothelial Cells, donor3	11681-122H7	87.33	10.31	6.42	5.27	1.15
Urothelial cells, donor0	11216-116B1	94.95	8.25	9.81	8.02	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	27.58	16.91	12.46	5.34	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	37.17	22.87	17.16	8.58	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	31.49	19.17	8.90	4.11	3.42
Whole blood (ribopure), donor090325, donation1	12176-128I7	38.91	14.12	7.58	3.79	1.03
Whole blood (ribopure), donor090325, donation2	12177-128I8	31.96	15.69	10.46	5.23	3.49
Whole blood (ribopure), donor090612, donation1	12182-129A4	33.32	17.70	9.37	2.08	2.08
Whole blood (ribopure), donor090612, donation2	12183-129A5	33.96	15.60	9.18	1.84	1.84
Whole blood (ribopure), donor090612, donation3	12184-129A6	39.25	14.61	9.13	4.56	1.83
Wilms' tumor cell line:G-401	10809-111A8	124.22	6.41	3.95	7.65	0.25
Wilms' tumor cell line:HFWT	10597-108E3	80.08	2.64	1.76	5.28	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	107.54	18.71	21.23	9.50	2.79
achilles tendon, donor2	10292-104G4	33.06	12.40	8.27	6.20	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	60.93	6.37	5.61	4.84	1.27
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	66.87	17.18	11.61	8.59	1.16
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	59.24	10.21	10.92	4.04	3.56
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	81.09	16.87	22.31	8.71	4.35
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	75.05	19.11	30.64	6.75	3.94
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	106.16	32.15	30.88	14.80	7.82
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	94.46	29.94	19.33	11.16	2.72
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	210.18	96.94	64.77	24.68	7.05
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	105.36	29.81	13.48	9.39	2.04
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	147.16	27.57	22.13	16.31	2.72
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	86.48	22.63	13.98	10.12	1.66
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	140.42	19.50	11.70	19.50	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	79.47	14.87	23.94	9.53	3.49
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	74.82	31.33	18.12	12.43	2.85
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	83.87	37.11	20.16	9.35	2.92
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	72.50	24.17	17.20	13.48	1.39
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	87.60	81.84	45.24	13.98	3.70
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	215.17	62.62	22.71	59.24	1.53
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	135.27	58.89	23.04	24.75	2.13
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	134.97	58.23	27.90	23.66	3.64
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	133.11	60.42	21.90	22.87	1.68
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	46.78	33.63	21.61	7.13	2.90
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	41.36	15.68	10.34	8.34	1.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	111.49	16.72	5.57	5.57	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	82.87	46.33	21.85	11.30	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	51.46	14.83	21.37	6.11	1.74
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	159.33	41.24	16.87	3.75	5.62
adenocarcinoma cell line:IM95m	10796-110I4	118.46	21.67	8.24	14.60	0.47
adipose tissue, adult, pool1	10010-101C1	25.59	11.63	10.24	3.88	2.64
adipose, donor1	10184-103D4	143.67	3.52	2.35	4.10	0.59
adipose, donor2	10185-103D5	122.47	6.08	3.65	8.11	1.22
adipose, donor3	10186-103D6	119.53	5.99	3.54	9.53	1.36
adipose, donor4	10187-103D7	104.01	6.93	4.33	2.60	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	218.42	20.52	14.84	23.67	2.53
adrenal gland, adult, pool1	10081-102A9	87.30	7.28	7.28	21.83	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	70.84	14.01	11.34	9.34	3.60
alveolar cell carcinoma cell line:SW 1573	10708-109H6	46.09	8.58	4.29	7.15	2.14
amniotic membrane cells, donor1	12235-129G3	70.25	16.00	15.30	10.90	3.71
amniotic membrane cells, donor2	12236-129G4	191.03	20.29	21.30	22.31	4.73
amniotic membrane cells, donor3	12237-129G5	48.02	15.91	12.67	5.89	2.65
amygdala - adult, donor10196	10167-103B5	28.46	3.56	2.37	1.19	0.00
amygdala, adult, donor10252	10151-102I7	40.76	6.89	3.65	3.85	0.20
amygdala, newborn, donor10223	10360-105E9	33.25	13.88	8.07	5.81	1.29
anaplastic carcinoma cell line:8305C	10428-106D5	98.04	13.11	9.17	9.80	1.91
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	105.24	20.96	7.72	13.90	1.99
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	179.04	1.34	0.33	3.01	0.00
aorta, adult, pool1	10052-101G7	80.02	8.04	8.24	9.22	2.16
appendix, adult	10189-103D9	60.55	10.48	8.54	10.87	3.10
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	128.63	2.41	1.38	7.57	0.34
artery, adult	10190-103E1	36.68	1.36	0.00	9.51	2.72
astrocytoma cell line:TM-31	10425-106D2	99.52	3.48	2.75	4.49	0.43
b cell line:RPMI1788	10427-106D4	104.98	8.18	7.14	9.07	1.04
basal cell carcinoma cell line:TE 354.T	10702-109G9	96.83	23.03	17.20	16.37	3.61
bile duct carcinoma cell line:HuCCT1	10432-106D9	71.25	16.08	7.24	9.03	0.99
bile duct carcinoma cell line:TFK-1	10496-107C1	55.74	5.19	1.00	5.36	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	101.22	57.60	31.88	19.01	1.68
bladder, adult, pool1	10011-101C2	34.11	6.63	8.04	5.11	2.50
blood, adult, pool1	10053-101G8	62.01	6.64	11.07	4.43	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	76.21	23.98	17.13	11.99	0.86
bone marrow, adult	10192-103E3	51.96	25.64	19.57	10.12	6.75
brain, adult, donor1	10084-102B3	56.38	6.15	2.05	11.28	0.00
brain, adult, pool1	10012-101C3	28.17	5.01	3.01	4.34	0.56
brain, fetal, pool1	10085-102B4	104.18	5.34	0.00	21.37	2.67
breast carcinoma cell line:MCF7	10482-107A5	101.42	13.88	6.28	9.25	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	86.50	6.62	3.50	7.74	0.75
breast, adult, donor1	10080-102A8	51.77	10.10	8.21	9.47	1.26
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	125.51	21.60	12.32	11.94	1.65
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	292.21	13.61	8.35	17.32	1.24
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	110.74	9.44	10.36	8.29	3.22
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	60.76	15.98	12.10	9.20	3.87
carcinoid cell line:NCI-H1770	10703-109H1	113.78	0.94	0.94	5.17	0.00
carcinoid cell line:NCI-H727	10735-110B6	77.55	10.17	6.13	5.80	1.53
carcinoid cell line:SK-PN-DW	10719-109I8	82.39	2.22	0.95	4.44	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	120.05	7.99	5.32	9.32	1.06
caudate nucleus - adult, donor10196	10177-103C6	33.39	6.91	4.61	6.91	0.00
caudate nucleus, adult, donor10252	10164-103B2	51.37	6.19	4.35	3.51	1.17
caudate nucleus, adult, donor10258	10379-105H1	31.33	4.58	3.82	2.29	0.76
caudate nucleus, newborn, donor10223	10354-105E3	27.47	17.21	8.06	3.66	0.73
cerebellum - adult, donor10196	10173-103C2	34.96	2.91	0.00	8.74	0.00
cerebellum, adult, donor10252	10166-103B4	42.49	3.42	1.49	2.99	0.43
cerebellum, adult, pool1	10083-102B2	50.36	4.14	1.38	3.79	0.69
cerebellum, newborn, donor10223	10357-105E6	29.89	10.79	3.32	2.49	1.66
cerebral meninges, adult	10188-103D8	28.74	4.54	3.78	6.30	0.25
cerebrospinal fluid, donor2	10294-104G6	19.73	2.19	1.46	3.65	0.73
cervical cancer cell line:D98-AH2	10552-107I3	89.86	9.20	3.74	9.92	0.86
cervical cancer cell line:ME-180	10553-107I4	60.49	6.13	2.49	3.15	0.83
cervix, adult, pool1	10013-101C4	62.68	9.24	10.81	5.88	3.15
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	183.09	22.57	9.89	24.11	2.23
chondrosarcoma cell line:SW 1353	10700-109G7	67.93	10.45	11.76	9.14	1.31
choriocarcinoma cell line:BeWo	10423-106C9	169.26	6.84	4.35	9.44	1.62
choriocarcinoma cell line:SCH	10785-110H2	151.06	4.44	1.11	7.89	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	189.27	9.25	1.66	11.86	0.71
chorionic membrane cells, donor1	12238-129G6	135.05	16.81	17.67	18.52	3.99
chorionic membrane cells, donor2	12239-129G7	166.25	17.10	9.94	14.12	0.99
chorionic membrane cells, donor3	12240-129G8	170.89	18.13	12.09	12.64	2.20
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	56.55	16.16	23.23	8.08	10.10
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	71.46	53.40	56.67	12.10	8.64
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	185.42	40.97	13.52	22.17	0.63
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	51.87	20.80	10.27	7.19	0.51
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	59.74	23.22	10.64	7.74	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	40.72	19.34	12.83	5.90	1.22
chronic myelogenous leukemia cell line:K562	10454-106G4	75.97	34.45	10.89	13.25	2.36
chronic myelogenous leukemia cell line:KU812	10409-106B4	119.37	19.29	9.90	12.77	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	215.32	13.26	7.54	17.14	1.83
clear cell carcinoma cell line:TEN	10636-108I6	149.74	15.96	9.89	12.32	2.08
colon carcinoma cell line:CACO-2	10513-107D9	168.40	15.92	3.84	8.60	1.28
colon carcinoma cell line:COLO-320	10420-106C6	108.70	5.32	4.56	7.98	0.38
colon, adult, donor1	10082-102B1	139.23	30.94	10.71	13.09	3.57
colon, adult, pool1	10014-101C5	60.87	10.69	6.46	5.05	1.53
colon, fetal, donor1	10070-101I7	82.19	9.89	11.12	11.12	2.47
common myeloid progenitor CMP, donor1	12130-128D6	146.67	18.33	22.92	0.00	4.58
common myeloid progenitor CMP, donor2	12134-128E1	200.29	0.00	25.04	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	107.93	10.20	2.97	9.77	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	130.71	12.07	1.81	11.77	0.45
cord blood derived cell line:COBL-a untreated	10449-106F8	138.19	13.40	2.68	14.10	0.85
corpus callosum, adult, pool1	10042-101F6	34.83	6.52	6.19	7.52	1.44
cruciate ligament, donor2	10295-104G7	29.18	10.54	8.10	4.05	0.81
diaphragm, fetal, donor1	10069-101I6	62.60	6.42	4.82	9.63	4.01
diencephalon, adult	10193-103E4	38.40	5.04	5.04	5.52	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	48.68	8.27	7.58	3.21	0.92
ductal cell carcinoma cell line:KLM-1	10438-106E6	85.39	11.28	7.69	6.15	2.05
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	81.85	14.44	10.59	11.07	0.48
ductus deferens, adult	10196-103E7	108.14	10.47	8.97	10.47	2.49
duodenum, fetal, donor1, tech_rep1	10071-101I8	139.70	11.52	8.64	23.04	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	97.84	11.77	18.39	7.36	1.47
dura mater, adult, donor1	10041-101F5	85.97	21.56	18.33	12.80	3.55
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	80.61	14.66	4.66	5.33	0.44
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	99.16	10.60	4.59	6.30	0.72
embryonic pancreas cell line:1B2C6	10604-108F1	62.28	4.93	1.85	4.93	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	70.23	7.27	4.84	7.27	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	68.23	5.56	0.93	8.34	0.31
embryonic pancreas cell line:2C6	10603-108E9	53.85	6.57	1.31	7.88	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	165.59	6.03	3.35	7.04	1.68
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	102.94	13.23	7.97	18.49	1.45
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	85.55	7.72	4.02	5.15	0.48
epidermoid carcinoma cell line:A431	10426-106D3	101.04	15.56	10.89	7.23	1.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	95.47	21.12	9.90	8.03	0.99
epididymis, adult	10197-103E8	99.00	10.88	7.74	12.35	2.09
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	102.72	14.55	7.45	12.06	0.89
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	69.21	8.65	7.47	7.86	1.57
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	42.85	3.15	1.31	1.83	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	38.68	2.56	1.18	2.36	0.49
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	45.04	2.80	0.90	3.25	0.34
esophagus, adult, pool1	10015-101C6	42.26	7.75	8.28	5.84	2.02
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	132.75	5.76	2.25	10.39	1.13
eye - muscle inferior rectus, donor1	10272-104E2	28.97	9.66	12.07	7.24	2.41
eye - muscle lateral, donor2	10298-104H1	23.15	4.21	0.00	0.00	2.10
eye - muscle medial, donor2	10299-104H2	17.86	7.44	8.93	1.49	2.98
eye - muscle superior, donor2	10297-104G9	37.83	11.46	3.44	5.73	2.29
eye - vitreous humor, donor1	10268-104D7	18.95	7.29	5.83	4.37	1.46
eye, fetal, donor1	10054-101G9	83.39	10.17	9.66	9.41	1.78
fibrosarcoma cell line:HT-1080	10758-110E2	146.18	13.59	7.44	16.93	0.38
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	139.84	21.84	11.87	22.08	3.32
frontal lobe, adult, pool1	10040-101F4	35.47	4.79	2.06	5.54	0.84
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	138.72	13.21	6.31	10.51	1.50
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	127.10	44.71	38.22	26.33	6.86
gall bladder, adult	10198-103E9	68.81	14.49	7.24	7.97	2.17
gamma delta positive T cells, donor1	11937-126A2	98.24	18.25	24.70	8.05	4.83
gamma delta positive T cells, donor2	11938-126A3	70.96	18.30	29.13	10.83	6.72
gastric adenocarcinoma cell line:MKN1	10614-108G2	163.90	14.15	8.24	13.10	1.06
gastric adenocarcinoma cell line:MKN45	10612-108F9	238.87	37.52	17.02	19.53	2.13
gastric cancer cell line:AZ521	10549-107H9	139.85	7.87	3.44	10.66	0.16
gastric cancer cell line:GSS	10560-108A2	55.83	6.41	4.58	3.66	2.75
gastrointestinal carcinoma cell line:ECC12	10615-108G3	144.16	10.51	6.63	6.63	0.69
giant cell carcinoma cell line:LU65	10487-107B1	32.70	10.33	3.44	8.26	0.46
giant cell carcinoma cell line:Lu99B	10433-106E1	66.62	6.30	7.14	8.68	0.98
glassy cell carcinoma cell line:HOKUG	10688-109F4	98.02	11.22	3.99	9.48	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	37.68	9.61	7.71	7.81	2.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	48.03	9.41	7.58	10.11	3.09
glioblastoma cell line:T98G	10485-107A8	78.59	18.87	14.24	11.81	2.10
glioma cell line:GI-1	10413-106B8	124.47	10.25	10.84	14.64	1.46
globus pallidus - adult, donor10196	10175-103C4	26.24	5.10	2.19	7.29	1.46
globus pallidus, adult, donor10252	10161-103A8	36.37	9.52	7.32	4.39	1.95
globus pallidus, adult, donor10258	10367-105F7	28.75	9.58	6.85	6.85	1.37
globus pallidus, newborn, donor10223	10364-105F4	30.38	21.85	11.19	3.73	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	168.85	58.73	17.13	24.47	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	240.42	76.50	10.93	21.86	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	219.52	47.04	31.36	20.91	5.23
granulosa cell tumor cell line:KGN	10624-108H3	92.80	5.44	4.80	6.72	0.32
hIPS +CCl2, biol_rep1	14383-156B9	67.49	3.21	2.75	3.67	0.00
hIPS +CCl2, biol_rep2	14384-156C1	47.10	5.03	2.74	2.74	0.00
hIPS +CCl2, biol_rep3	14385-156C2	52.17	5.15	3.22	3.22	0.64
hIPS, biol_rep1	14380-156B6	57.49	7.19	1.44	0.00	0.00
hIPS, biol_rep2	14381-156B7	69.96	4.80	5.49	4.12	0.00
hIPS, biol_rep3	14382-156B8	23.17	11.03	2.21	4.41	0.00
hairy cell leukemia cell line:Mo	10712-109I1	85.92	10.34	6.90	10.34	0.86
heart - mitral valve, adult	10205-103F7	45.14	10.46	8.97	4.78	2.69
heart - pulmonic valve, adult	10206-103F8	41.31	6.28	5.49	5.75	0.78
heart - tricuspid valve, adult	10207-103F9	49.13	25.81	30.81	8.33	5.83
heart, adult, diseased post-infarction, donor1	10050-101G5	153.04	13.88	7.55	15.10	1.22
heart, adult, diseased, donor1	10051-101G6	98.37	15.76	11.92	10.22	3.41
heart, adult, pool1	10016-101C7	64.39	10.81	9.43	6.21	2.99
heart, fetal, pool1	10046-101G1	60.48	8.21	6.16	5.24	3.18
hepatic mesenchymal tumor cell line:LI90	10778-110G4	154.26	26.53	16.35	17.59	2.47
hepatoblastoma cell line:HuH-6	10633-108I3	168.86	7.14	5.95	4.76	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	203.31	4.64	2.21	5.08	0.11
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	214.95	3.16	2.67	5.83	0.36
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	194.12	5.05	2.22	6.87	0.30
hepatoma cell line:Li-7	10484-107A7	79.85	6.34	2.89	5.12	0.44
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	134.87	10.95	8.04	9.45	0.70
hippocampus - adult, donor10196	10169-103B7	32.18	4.73	2.84	5.68	0.95
hippocampus, adult, donor10252	10153-102I9	34.70	6.33	3.27	4.90	0.61
hippocampus, adult, donor10258	10374-105G5	9.46	5.98	2.49	2.49	0.00
hippocampus, newborn, donor10223	10363-105F3	30.67	19.74	6.70	4.23	2.11
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	151.37	6.10	7.93	6.71	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	129.20	5.69	2.95	3.93	0.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	110.95	5.59	2.54	5.84	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	94.17	1.69	0.56	3.38	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	123.94	0.52	0.77	2.32	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	97.18	1.52	0.38	2.66	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	79.12	3.50	2.04	8.47	1.46
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	115.69	3.66	3.66	6.89	0.43
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	70.90	6.26	2.09	1.67	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	83.59	5.68	3.79	9.00	0.47
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	113.95	9.00	5.63	9.00	0.64
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	93.59	6.06	5.39	9.43	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	138.96	3.44	2.82	5.63	1.10
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	140.51	3.44	2.46	5.40	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	91.64	5.24	1.75	1.75	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	147.19	2.48	1.15	4.58	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	125.59	2.62	0.44	3.49	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	112.45	2.50	0.50	5.00	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	120.38	5.09	3.58	9.04	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	148.24	5.91	5.00	5.46	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	99.61	5.64	2.82	7.83	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	120.19	6.21	5.72	8.49	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	129.19	4.35	5.23	9.29	1.45
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	100.44	5.68	6.88	10.16	1.49
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	133.20	7.21	2.77	3.88	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	145.50	4.56	6.56	6.28	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	137.19	5.31	6.53	7.35	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	110.91	2.82	1.06	4.22	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	133.03	5.07	1.58	5.70	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	104.71	3.93	1.51	6.66	0.61
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	122.04	7.24	1.03	10.86	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	131.50	4.65	3.98	7.97	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	88.76	6.67	5.39	6.41	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	113.51	9.71	8.95	6.90	2.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	134.79	6.06	6.06	12.87	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	90.06	11.76	5.38	6.72	2.02
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	134.52	4.35	3.14	6.04	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	88.69	2.67	3.57	5.35	0.89
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	128.29	10.24	4.39	5.85	0.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	114.00	3.36	1.22	5.20	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	120.37	3.25	0.00	13.01	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	90.68	0.66	0.99	4.96	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	120.41	3.83	2.74	7.66	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	93.37	3.62	2.53	9.05	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	76.16	3.91	2.85	6.76	0.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	60.86	3.58	2.39	3.58	2.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	91.68	4.06	3.79	9.07	1.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	71.39	7.54	1.89	6.47	0.81
immature langerhans cells, donor1	11904-125F5	64.41	21.79	20.34	3.15	4.84
immature langerhans cells, donor2	11905-125F6	76.04	15.84	12.67	3.17	1.58
insula, adult, pool1	10039-101F3	45.05	4.54	3.22	5.39	0.38
keratoacanthoma cell line:HKA-1	10791-110H8	154.12	5.85	2.93	10.73	0.98
kidney, adult, pool1	10017-101C8	72.39	7.31	6.11	5.71	0.80
kidney, fetal, pool1	10045-101F9	75.62	6.22	6.01	3.61	1.41
large cell lung carcinoma cell line:IA-LM	10509-107D5	92.03	7.10	4.83	8.38	2.27
large cell lung carcinoma cell line:NCI-H460	10839-111E2	83.08	8.99	4.56	5.11	0.69
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	77.44	12.29	4.04	8.62	0.73
left atrium, adult, donor1	10079-102A7	65.93	7.63	3.81	11.44	1.09
left ventricle, adult, donor1	10078-102A6	88.49	13.15	16.18	8.60	3.54
leiomyoblastoma cell line:G-402	10721-110A1	158.97	8.21	5.75	15.87	0.27
leiomyoma cell line:10964C	10569-108B2	155.91	43.11	25.87	29.10	2.16
leiomyoma cell line:15242A	10570-108B3	107.61	33.15	14.67	14.67	1.63
leiomyoma cell line:15425	10571-108B4	118.01	28.17	21.37	19.18	1.94
leiomyosarcoma cell line:Hs 5.T	10722-110A2	107.94	12.70	12.70	19.05	6.35
lens epithelial cell line:SRA 01/04	10647-109A8	100.37	17.77	13.59	12.55	3.14
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	111.56	10.86	4.96	6.38	0.35
liposarcoma cell line:KMLS-1	10782-110G8	153.40	24.52	16.71	15.46	2.50
liposarcoma cell line:SW 872	10726-110A6	112.34	15.47	10.84	10.48	1.83
liver, adult, pool1	10018-101C9	94.48	8.59	4.05	9.40	0.65
liver, fetal, pool1	10086-102B5	95.95	15.05	4.70	8.47	0.94
locus coeruleus - adult, donor10196	10182-103D2	20.71	4.08	2.92	3.21	0.44
locus coeruleus, adult, donor10252	10165-103B3	32.11	7.38	4.61	3.51	0.55
locus coeruleus, adult, donor10258	10375-105G6	37.81	7.34	6.49	8.46	0.85
locus coeruleus, newborn, donor10223	10362-105F2	15.14	12.62	4.63	2.94	0.42
lung adenocarcinoma cell line:A549	10499-107C4	94.11	7.47	4.57	7.89	0.69
lung adenocarcinoma cell line:PC-14	10408-106B3	67.56	17.24	8.96	9.65	3.45
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	109.14	6.99	6.59	7.91	1.71
lung, adult, pool1	10019-101D1	49.14	9.69	8.51	5.08	1.30
lung, fetal, donor1	10068-101I5	41.38	11.99	9.42	4.28	1.71
lung, right lower lobe, adult, donor1	10075-102A3	70.11	20.62	11.91	8.71	1.83
lymph node, adult, donor1	10077-102A5	121.18	20.35	11.83	11.83	2.84
lymphangiectasia cell line:DS-1	10727-110A7	250.74	34.63	24.11	29.37	5.04
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	68.07	6.04	4.38	3.32	1.21
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	66.26	25.48	14.44	3.40	1.70
mature adipocyte, donor1	12231-129F8	45.73	17.32	7.55	12.88	1.33
mature adipocyte, donor2	12232-129F9	34.24	13.70	6.85	7.26	2.08
mature adipocyte, donor3	12233-129G1	32.24	11.38	8.30	8.77	2.13
mature adipocyte, donor4	12234-129G2	36.06	10.53	8.42	5.00	5.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	204.19	27.64	16.92	25.97	3.81
medial frontal gyrus - adult, donor10196	10170-103B8	39.48	1.13	1.13	5.64	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	26.85	7.36	2.57	2.57	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	34.31	5.08	2.54	5.72	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	23.46	8.10	4.69	4.69	1.71
medial temporal gyrus - adult, donor10196	10183-103D3	30.38	3.04	1.69	2.53	0.51
medial temporal gyrus, adult, donor10252	10156-103A3	33.11	4.88	1.70	4.03	0.42
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	13.48	5.78	1.93	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	28.71	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	32.66	13.64	6.10	4.67	0.36
medulla oblongata - adult, donor10196	10174-103C3	27.91	3.24	6.49	6.49	0.00
medulla oblongata, adult, donor10252	10155-103A2	42.26	6.81	5.11	4.64	0.46
medulla oblongata, adult, pool1	10038-101F2	31.26	6.04	7.10	3.84	1.71
medulla oblongata, newborn, donor10223	10361-105F1	28.82	12.85	7.64	4.51	2.43
medulloblastoma cell line:D283 Med	10838-111E1	93.88	2.44	1.11	5.09	0.00
medulloblastoma cell line:ONS-76	10759-110E3	142.45	16.38	9.90	14.06	1.35
melanoma cell line:COLO 679	10514-107E1	73.17	32.20	18.97	11.21	0.86
melanoma cell line:G-361	10465-106H6	86.33	15.74	7.87	11.94	1.63
meningioma cell line:HKBMM	10691-109F7	91.72	18.45	9.95	14.11	2.35
merkel cell carcinoma cell line:MKL-1	10843-111E6	98.69	1.76	1.76	3.52	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	139.46	5.18	2.85	9.07	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	121.06	26.70	16.11	16.88	1.23
mesenchymal precursor cell - adipose, donor2	11748-123G2	110.34	16.72	8.36	14.00	1.45
mesenchymal precursor cell - adipose, donor3	11749-123G3	89.45	18.22	13.25	11.59	2.07
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	79.23	13.20	9.83	11.10	1.83
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	128.64	12.71	7.90	13.48	1.54
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	93.70	29.85	23.60	18.74	3.47
mesenchymal precursor cell - cardiac, donor1	11752-123G6	194.29	39.13	10.98	23.34	1.37
mesenchymal precursor cell - cardiac, donor2	11753-123G7	111.57	16.91	8.63	11.73	1.50
mesenchymal precursor cell - cardiac, donor3	11754-123G8	109.16	19.90	8.22	14.46	1.99
mesenchymal precursor cell - cardiac, donor4	11755-123G9	128.96	17.56	7.16	16.34	0.95
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	96.45	13.09	6.26	10.95	1.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	128.12	24.37	13.83	11.86	1.32
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	115.26	13.15	5.53	11.07	1.11
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	104.38	23.04	11.17	16.06	1.05
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	113.31	24.91	13.68	17.15	1.84
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	79.80	21.57	11.50	11.14	1.08
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	122.90	13.35	6.72	12.52	1.24
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	59.51	14.36	6.84	6.16	0.91
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	90.62	12.17	10.07	7.13	1.26
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	108.04	13.75	8.97	10.31	1.79
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	118.34	9.54	6.39	8.75	0.70
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	121.12	19.88	14.36	13.99	2.21
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	79.55	16.60	10.87	10.30	1.14
mesenchymal stem cell line:Hu5/E18	10568-108B1	90.10	21.05	12.21	13.47	3.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	103.21	22.38	10.96	11.87	1.83
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	87.73	16.37	12.79	11.51	0.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	91.88	21.46	13.35	13.09	2.09
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	87.80	16.64	14.17	14.17	2.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	77.90	17.65	15.06	15.30	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	97.14	20.65	9.48	15.57	1.35
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	82.52	18.47	18.47	13.75	1.96
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	79.70	17.15	14.83	11.12	1.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	144.91	48.30	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	94.60	19.90	20.19	17.88	2.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	92.81	19.19	14.28	14.06	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	92.78	23.55	15.62	12.50	2.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	75.53	20.53	13.20	17.60	2.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	81.90	21.15	14.43	12.42	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	95.39	20.88	18.01	15.15	2.87
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	78.18	23.20	16.75	13.32	1.29
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	82.03	13.67	5.47	13.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	103.30	20.66	20.66	15.49	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	95.49	25.01	15.26	15.59	1.62
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	90.21	18.91	11.64	23.28	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	122.61	27.19	27.72	18.66	2.13
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	95.68	22.08	14.72	15.54	3.27
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	86.68	25.27	19.82	14.77	1.94
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	113.33	20.99	14.69	8.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	88.42	16.89	15.90	13.91	3.97
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	81.04	42.90	14.30	19.07	9.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	83.61	11.27	13.64	15.42	1.78
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	98.70	24.37	19.50	18.28	2.44
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	81.16	81.16	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	96.27	24.70	14.57	15.83	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	112.78	19.31	19.31	9.66	3.45
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	111.76	25.79	8.60	8.60	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	79.84	27.94	19.96	23.95	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	82.65	24.11	20.66	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	112.46	20.78	16.71	17.11	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	116.78	21.45	15.09	11.92	1.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	86.07	11.79	4.13	12.38	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	89.46	13.71	7.79	12.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	81.54	13.37	9.36	8.02	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	82.79	5.91	4.73	11.83	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	74.47	17.98	7.70	10.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	73.66	8.26	7.57	11.01	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	56.41	14.35	6.43	11.38	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	49.35	12.34	5.61	5.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	51.52	13.99	4.45	9.54	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	42.31	6.45	2.42	10.07	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	74.14	8.72	6.54	17.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	53.22	11.40	2.53	12.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	64.33	7.28	2.43	5.46	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	103.94	27.11	0.00	9.04	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	79.90	9.88	3.29	11.53	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	55.36	13.49	10.72	9.72	1.39
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	67.82	14.28	9.73	14.28	0.97
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	73.34	15.28	8.15	14.26	2.04
mesodermal tumor cell line:HIRS-BM	10696-109G3	52.61	5.42	3.87	7.74	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	117.41	13.94	6.38	18.90	3.31
mesothelioma cell line:ACC-MESO-4	10494-107B8	201.09	8.57	4.87	12.74	0.93
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	42.74	4.27	8.55	4.27	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	68.95	9.66	4.93	6.68	0.62
mesothelioma cell line:Mero-25	10850-111F4	87.60	6.58	2.04	5.67	1.13
mesothelioma cell line:Mero-41	10851-111F5	108.79	24.94	21.27	22.49	3.67
mesothelioma cell line:Mero-48a	10852-111F6	55.36	12.18	4.43	7.09	1.55
mesothelioma cell line:Mero-82	10853-111F7	91.72	13.14	6.57	8.15	0.53
mesothelioma cell line:Mero-83	10854-111F8	48.68	4.60	1.02	3.74	0.17
mesothelioma cell line:Mero-84	10855-111F9	67.49	7.33	2.78	4.80	0.51
mesothelioma cell line:Mero-95	10856-111G1	108.28	9.52	6.42	7.25	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	52.51	20.54	12.26	9.77	3.15
mesothelioma cell line:NCI-H226	10846-111E9	87.42	9.23	4.89	6.88	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	107.79	27.50	18.45	17.77	3.25
mesothelioma cell line:NCI-H28	10845-111E8	39.19	8.40	4.07	7.63	1.27
mesothelioma cell line:No36	10857-111G2	49.91	5.87	4.57	3.91	0.33
mesothelioma cell line:ONE58	10858-111G3	47.42	16.26	11.65	5.69	0.81
migratory langerhans cells, donor1	11901-125F2	39.15	11.32	7.29	4.41	1.54
migratory langerhans cells, donor2	11902-125F3	37.25	8.43	10.14	4.76	1.34
migratory langerhans cells, donor3	11903-125F4	57.25	8.79	6.82	4.13	2.33
mixed mullerian tumor cell line:HTMMT	10689-109F5	159.00	16.98	12.41	12.41	1.31
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	182.90	15.05	7.84	9.75	1.48
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	146.74	16.36	8.06	16.59	1.38
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	81.25	6.28	2.09	5.14	1.33
myelodysplastic syndrome cell line:SKM-1	10772-110F7	149.68	44.17	26.98	17.74	2.40
myeloma cell line:PCM6	10474-106I6	145.09	16.41	5.34	14.43	1.38
myxofibrosarcoma cell line:MFH-ino	10600-108E6	68.48	10.15	1.52	5.58	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	98.66	35.31	22.75	16.08	2.94
nasal epithelial cells, donor1, tech_rep1	12226-129F3	91.59	25.29	25.18	13.04	3.12
nasal epithelial cells, donor1, tech_rep2	12226-129F3	84.57	29.78	26.25	12.50	3.31
nasal epithelial cells, donor2	12227-129F4	83.35	13.25	7.73	7.18	1.10
neuroblastoma cell line:CHP-134	10508-107D4	55.90	0.46	0.46	2.30	0.23
neuroblastoma cell line:NB-1	10539-107G8	42.66	2.81	4.68	5.80	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	159.01	3.16	2.11	5.90	0.00
neuroblastoma cell line:NH-12	10555-107I6	75.47	0.93	1.49	3.35	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	91.09	2.37	2.61	3.08	0.71
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	88.69	3.01	3.80	5.70	0.48
neuroectodermal tumor cell line:TASK1	10774-110F9	206.29	6.44	4.03	5.43	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	80.74	8.90	14.62	8.26	3.81
neurofibroma cell line:Hs 53.T	10729-110A9	117.38	14.37	7.19	12.78	1.60
neutrophil PMN, donor1	12133-128D9	59.50	14.87	59.50	0.00	0.00
neutrophil PMN, donor2	12137-128E4	66.40	26.56	13.28	13.28	13.28
neutrophil PMN, donor3	12141-128E8	75.77	47.35	18.94	0.00	9.47
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	88.28	20.13	18.77	8.29	2.71
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	52.83	5.60	4.00	8.81	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	200.06	20.84	13.47	24.69	2.24
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	127.44	22.86	12.09	16.55	2.10
nucleus accumbens, adult, pool1	10037-101F1	39.93	4.50	2.72	4.12	0.66
occipital cortex - adult, donor10196	10172-103C1	10.30	2.06	0.00	6.18	0.00
occipital cortex, adult, donor10252	10163-103B1	33.55	5.64	2.68	2.95	0.54
occipital cortex, newborn, donor10223	10355-105E4	25.48	13.47	6.91	4.37	1.46
occipital lobe, adult, donor1	10076-102A4	53.79	6.04	2.62	7.61	1.05
occipital lobe, fetal, donor1	10073-102A1	95.69	5.15	3.43	12.44	0.43
occipital pole, adult, pool1	10036-101E9	35.64	3.55	1.81	3.63	0.71
olfactory region, adult	10195-103E6	32.67	5.92	2.67	5.35	0.19
optic nerve, donor1	10277-104E7	32.02	16.01	16.01	2.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	158.10	12.76	5.81	9.80	0.68
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	87.10	6.05	6.18	5.22	0.82
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	64.00	4.06	4.74	2.71	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	78.31	6.01	4.39	3.35	0.58
osteoclastoma cell line:Hs 706.T	10704-109H2	92.01	17.93	10.58	14.40	2.65
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	96.24	9.34	5.61	6.54	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	140.38	26.93	23.96	14.21	4.03
ovary, adult, pool1	10020-101D2	64.12	6.81	4.63	4.89	1.66
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	175.99	27.50	17.05	14.85	2.02
pancreas, adult, donor1	10049-101G4	293.48	14.11	8.47	22.58	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	193.44	7.55	3.07	9.22	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	111.58	18.91	9.88	12.10	1.36
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	51.16	9.93	6.46	7.78	1.32
paracentral gyrus, adult, pool1	10035-101E8	35.42	5.22	3.39	3.57	0.92
parietal cortex, adult, donor10258	10373-105G4	22.02	3.67	0.73	2.94	0.00
parietal lobe - adult, donor10196	10171-103B9	26.33	8.46	0.94	0.94	0.00
parietal lobe, adult, donor10252	10157-103A4	28.22	5.13	2.85	4.28	0.29
parietal lobe, adult, pool1	10034-101E7	33.75	4.05	3.08	4.93	0.44
parietal lobe, fetal, donor1	10072-101I9	81.47	6.79	2.91	7.76	0.00
parietal lobe, newborn, donor10223	10356-105E5	28.79	12.71	5.61	5.61	1.87
parotid gland, adult	10199-103F1	118.40	20.35	12.33	8.63	4.32
penis, adult	10200-103F2	39.21	11.28	5.37	7.52	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	54.85	8.00	6.14	6.69	0.56
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	134.77	11.51	13.26	10.93	2.19
pineal gland - adult, donor10196	10179-103C8	41.93	5.16	3.87	3.23	0.65
pineal gland, adult, donor10252	10160-103A7	54.48	8.29	10.66	8.88	1.18
pineal gland, adult, donor10258	10377-105G8	25.08	10.03	1.25	2.51	0.63
pituitary gland - adult, donor10196	10180-103C9	81.96	4.05	2.02	6.07	0.00
pituitary gland, adult, donor10252	10162-103A9	93.29	6.25	2.61	8.34	0.00
pituitary gland, adult, donor10258	10378-105G9	108.11	4.26	2.55	12.77	0.85
placenta, adult, pool1	10021-101D3	102.99	25.48	19.67	15.16	4.62
plasma cell leukemia cell line:ARH-77	10840-111E3	90.05	10.20	8.74	8.87	0.53
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	93.69	24.90	20.54	15.88	5.91
pons, adult, pool1	10033-101E6	23.41	4.48	3.44	3.96	0.95
postcentral gyrus, adult, pool1	10032-101E5	34.17	4.88	2.01	4.45	0.70
promyelocytes/myelocytes PMC, donor1	12132-128D8	326.26	102.48	43.92	37.65	8.37
promyelocytes/myelocytes PMC, donor2	12136-128E3	236.85	44.06	55.08	33.05	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	187.77	93.89	23.47	23.47	0.00
prostate cancer cell line:DU145	10490-107B4	113.18	5.24	3.93	8.01	1.02
prostate cancer cell line:PC-3	10439-106E7	125.60	12.89	8.17	8.89	0.91
prostate, adult, pool1	10022-101D4	40.72	8.62	7.35	4.90	2.27
putamen, adult, donor10196	10176-103C5	56.18	2.60	2.60	5.90	0.94
putamen, adult, donor10252	10152-102I8	29.41	11.76	7.84	9.80	3.92
putamen, adult, donor10258, tech_rep1	10372-105G3	36.06	4.37	4.37	3.28	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	32.38	3.87	4.35	3.87	0.00
putamen, newborn, donor10223	10365-105F5	22.49	5.25	5.25	3.00	0.75
rectal cancer cell line:TT1TKB	10469-106I1	150.70	29.09	7.86	12.22	1.45
rectum, fetal, donor1	10067-101I4	147.45	13.91	11.13	4.17	4.17
renal cell carcinoma cell line:OS-RC-2	10411-106B6	125.29	48.76	57.24	16.54	12.93
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	72.49	20.71	16.57	14.50	6.63
retina, adult, pool1	10030-101E3	65.40	8.45	7.75	9.34	3.38
retinoblastoma cell line:Y79	10475-106I7	91.45	2.60	1.04	3.64	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	119.63	4.06	1.72	5.04	0.25
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	101.51	11.25	10.40	6.47	1.12
sacrococcigeal teratoma cell line:HTST	10695-109G2	121.26	17.43	11.37	15.91	2.27
salivary acinar cells, donor1	11771-123I7	66.20	5.34	2.43	4.37	0.16
salivary acinar cells, donor2	11772-123I8	63.06	4.41	2.48	3.03	0.96
salivary acinar cells, donor3	11773-123I9	49.65	7.94	0.66	3.97	0.00
salivary gland, adult, pool1	10093-102C3	76.07	18.87	11.44	13.73	2.86
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	46.96	7.08	5.82	5.65	0.17
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	62.89	7.41	6.35	10.34	0.47
seminal vesicle, adult	10201-103F3	122.22	13.76	7.94	11.64	1.59
serous adenocarcinoma cell line:JHOS-2	10639-108I9	87.45	12.15	11.66	7.04	2.19
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	61.15	19.63	16.10	7.05	2.26
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	42.15	35.12	27.10	10.04	8.03
serous cystadenocarcinoma cell line:HTOA	10693-109F9	196.11	10.75	5.24	11.42	0.81
signet ring carcinoma cell line:Kato III	10436-106E4	129.65	15.69	8.95	13.93	0.88
signet ring carcinoma cell line:NUGC-4	10483-107A6	74.19	9.55	3.61	8.13	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	24.12	3.55	4.26	4.26	2.13
skeletal muscle, adult, pool1	10023-101D5	44.86	6.84	5.40	3.96	0.96
skeletal muscle, fetal, donor1	10066-101I3	67.34	11.06	9.05	5.03	2.01
skin, adult, donor1	10074-102A2	108.56	6.79	6.79	13.57	6.79
skin, fetal, donor1	10065-101I2	92.79	9.47	13.26	15.15	2.52
small cell cervical cancer cell line:HCSC-1	10800-110I8	108.39	4.34	3.00	7.67	1.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	75.65	1.58	1.89	3.47	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	202.58	11.95	10.22	26.98	2.12
small cell lung carcinoma cell line:LK-2	10541-107H1	88.35	5.93	5.93	8.24	1.15
small cell lung carcinoma cell line:NCI-H82	10842-111E5	99.89	6.92	3.86	7.40	0.80
small cell lung carcinoma cell line:WA-hT	10562-108A4	166.92	3.49	1.09	5.01	0.00
small intestine, adult, pool1	10024-101D6	75.49	17.68	7.52	8.84	2.39
small intestine, fetal, donor1	10064-101I1	116.21	19.16	13.27	9.34	3.44
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	174.90	20.00	13.85	15.39	1.54
smooth muscle, adult, pool1	10048-101G3	48.07	7.75	6.20	6.46	1.29
somatostatinoma cell line:QGP-1	10781-110G7	131.06	28.68	6.97	19.30	0.54
spinal cord - adult, donor10196	10181-103D1	25.92	5.28	4.82	3.67	1.38
spinal cord, adult, donor10252	10159-103A6	22.08	5.52	4.34	4.34	0.39
spinal cord, adult, donor10258	10369-105F9	6.23	11.07	1.38	3.46	0.69
spinal cord, fetal, donor1	10056-101H2	85.99	11.59	10.37	10.37	0.61
spinal cord, newborn, donor10223	10359-105E8	32.14	16.53	9.64	7.35	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	116.94	17.62	9.71	12.99	1.49
spleen, adult, pool1	10025-101D7	58.37	15.09	10.90	6.17	1.21
spleen, fetal, pool1	10044-101F8	46.56	17.88	12.79	5.96	2.62
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	60.97	13.15	13.25	9.21	1.97
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	59.05	5.13	4.94	5.89	0.57
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	152.36	12.58	8.39	12.58	2.80
squamous cell carcinoma cell line:T3M-5	10616-108G4	75.06	21.89	13.68	8.99	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	91.06	34.22	14.18	12.83	1.80
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	60.58	10.17	6.35	3.81	2.12
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	63.88	3.81	3.81	3.38	0.42
stomach, fetal, donor1	10062-101H8	133.50	9.61	8.54	13.88	1.07
submaxillary gland, adult	10202-103F4	89.44	15.95	15.95	5.70	2.85
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	33.23	8.72	5.40	2.91	0.62
substantia nigra, adult, donor10258	10371-105G2	7.24	7.76	3.62	5.69	0.52
substantia nigra, newborn, donor10223	10358-105E7	23.32	17.66	9.89	4.24	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	120.82	3.44	3.21	8.48	1.15
temporal lobe, adult, pool1	10031-101E4	40.10	5.26	4.75	3.56	0.59
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	94.73	2.14	2.14	10.68	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	54.06	3.08	3.96	7.91	0.44
tenocyte, donor1	11763-123H8	136.85	26.88	26.53	17.11	3.84
tenocyte, donor2	11765-123I1	102.63	17.93	14.88	15.64	2.29
tenocyte, donor3	11768-123I4	102.67	20.76	17.79	17.79	5.93
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	236.92	11.56	3.74	11.56	0.34
teratocarcinoma cell line:NCR-G1	10798-110I6	132.10	5.40	4.01	4.62	0.77
teratocarcinoma cell line:PA-1	10807-111A6	141.34	11.31	7.44	9.45	1.86
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	171.38	5.08	3.05	6.47	0.51
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	102.11	2.27	3.03	4.54	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	85.50	1.96	0.33	2.51	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	122.14	8.47	6.51	4.56	0.65
testis, adult, pool1	10026-101D8	74.84	9.66	6.66	8.80	1.72
testis, adult, pool2	10096-102C6	97.43	21.65	9.02	15.79	0.90
thalamus - adult, donor10196	10168-103B6	17.66	5.52	2.21	4.42	2.21
thalamus, adult, donor10252	10154-103A1	30.63	8.44	5.94	3.13	0.78
thalamus, adult, donor10258, tech_rep1	10370-105G1	6.16	12.32	9.24	6.16	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	30.47	6.42	5.76	5.27	1.15
thalamus, newborn, donor10223	10366-105F6	19.56	18.41	6.90	4.03	4.03
throat, adult	10209-103G2	50.18	9.99	8.74	8.49	1.75
throat, fetal, donor1	10061-101H7	85.01	10.66	9.45	7.92	3.35
thymic carcinoma cell line:Ty-82	10803-111A2	176.08	3.58	1.59	5.76	0.20
thymus, adult, pool1	10027-101D9	55.47	7.95	15.51	4.18	4.27
thymus, fetal, pool1	10043-101F7	44.68	6.44	10.18	3.95	2.08
thyroid carcinoma cell line:KHM-5M	10776-110G2	88.82	33.11	18.22	10.64	2.79
thyroid carcinoma cell line:TCO-1	10783-110G9	181.04	28.36	12.71	19.42	3.07
thyroid, adult, pool1	10028-101E1	116.27	12.13	8.77	7.65	2.61
thyroid, fetal, donor1	10060-101H6	144.49	10.81	10.81	10.81	3.95
tongue epidermis (fungiform papillae), donor1	10288-104F9	64.67	12.32	9.24	3.08	3.08
tongue, adult	10203-103F5	38.38	8.61	7.91	6.05	2.33
tongue, fetal, donor1	10059-101H5	72.91	12.61	13.40	8.67	4.34
tonsil, adult, pool1	10047-101G2	73.73	11.22	10.72	6.71	3.41
trachea, adult, pool1	10029-101E2	55.46	12.68	17.59	7.85	2.62
trachea, fetal, donor1	10058-101H4	134.64	12.69	10.77	12.69	1.92
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	120.10	24.09	12.40	15.94	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	118.54	9.93	8.71	8.11	1.32
transitional-cell carcinoma cell line:JMSU1	10492-107B6	206.04	11.12	7.36	14.26	1.10
tridermal teratoma cell line:HGRT	10694-109G1	159.81	11.42	7.61	20.93	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	66.70	6.94	2.03	5.08	0.34
umbilical cord, fetal, donor1	10057-101H3	81.37	10.43	6.26	16.69	0.00
uterus, adult, pool1	10100-102D1	50.51	11.43	8.53	7.00	1.54
uterus, fetal, donor1	10055-101H1	123.89	13.31	12.80	8.19	1.54
vagina, adult	10204-103F6	40.06	12.28	7.75	4.52	1.29
vein, adult	10191-103E2	40.55	7.45	12.49	5.04	2.19
xeroderma pigentosum b cell line:XPL 17	10563-108A5	84.12	3.47	3.20	4.81	0.00